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INTRODUCTION 
In the modern sense teratology is the study of the 
causes, mechanisms, and manifestations of developmental 
deviations of a structural or a functional nature that 
usually, but not always, originate before birth (1). 
Included in this broad scope of teratology are congenital 
anomalies which are deviations from the normal, existing 
at birth. 
Since the earliest recordings of history, man has 
attempted to describe and explain the frequent cases of 
congenital abnormalities with which he has been confronted. 
For example: the Babylonians listed structural defects; 
the Bible has references to congenitally defective individ­
uals; and in more recent times, a familiar figure in liter­
ature is the Hunchback of Notre Dame, who exhibited structural 
anomalies. 
In the world today, the reported incidence of neonatal 
mortality (14% - 20%) due to congenital defects appears to 
be relatively uniform. This uniformity is reported despite 
marked differences in the overall incidence of neonatal 
mortality from all causes and differences in the level of 
medical care (2,3). Deleterious gene effects and chromosomal 
aberrations account for approximately JO¼ of the 40% known 
causes for malformations. The remaining 10% of malformations 
are caused by such extrirtsic factors as known viral 
infections and environmental teratogens, e.g. thalidomide 
and ionizing radiation (4). However, 60% of human 
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malformations have an unknown etiology and are possibly 
due to a complex interaction between environmental 
teratogens and genetic composition� 
In the United States, today, congenital anomalies 
have become the second (14%) leading cause of all infant 
deaths. From 4% to 7% of liveborn children are found to 
have some type of anomalies (2,4,5). Perhaps of more 
significance is the problem of mental subnormality. 
Approximately 3% of the three and one-half million 
children born per year in the United States will be mentally 
retarded. With the present state of knowledge, the etiology 
of mental retardation that can be attributed to viral 
infection is only 10% of these children. Over one-third 
of patients confined to hospitals for mental defectives 
may show developmental abnormalities of the brain. Minor 
abnormalities, particularly of late gestational develop­
ment,may well be one of the determinants of subtle 
differencies in mental potential (4). 
Traditionally, teratology has dealt mainly with 
structural defects. However, there is neither logic nor 
scientific basis for separating functional from structural 
defects when it can be shown that either may result from 
interference with the same developmental processes by the 
same type of causative agents (1). Recently, experimental 
teratogenic research has shifted from a purely descriptive 
science to one that has as its primary purpose the defin­
itions of sites and mechanisms of teratogenic actions, the 
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biochemistry and genetics of abnormal development, 
and the alterations of varying embryonic physiologic 
criteria, as they relate to birth defects. Such research 
has led to cumulative evidence which is highly suggestive 
that much of the unknown grou� of fetal abnormalities -is 
caused by viral teratogens (3). 
Gregg (7) in 1941 was one of the first to recognize 
viruses as teratogens when he observed the association of 
congenital cataracts with maternal rubella infection. Of 
all viral infections rubella is the most important known 
cause of hu�an fetal wastage and congenital malformation. 
The major fetal defects are cardiac lesions, cataracts and 
blindness, microcephaly, and mental retardation. The 
frequency of congenital anomalies approaches 50% when 
rubella infection occurs in the first month of pregnancy, 
22% the second month, and 6-10% when infection occurs 
between the third and fifth months (8). The mechanisms of 
teratogenesis for rubella appear to be a direct virus-cell 
effect which persists throughout gestation. Restriction of 
damage to certain organs apparently reflects, at least in 
part, the regenerative capacity of some tissues. Thus, 
the clinical manifestations of congenital rubella are 
apparently largely due to a direct infection and destruc­
tion.of rapidly proliferating and differentiating cells at 
a critical period of organogene�is (9). 
More recently there has been an active interest in 
determining whether other congenital malformations or 
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fetal deaths have a viral etiology. A number of animal 
models with a wide spectrum of viruses inducing central 
nervous system malformations, have been described (6). 
Each of the animal malformations induced by viruses has a 
counterpart in man. The experimental studies demonstrate 
the potential of viruses to induce such defects even with 
minor or clinically inapparent maternal or neonatal 
infections. There may be no demonstratable maternal 
effects from a teratogen that produces extens�ve fetal 
damage (3). 
Three possible mechanisms for adverse effects by a 
virus upon the fetus include: (a) direct invasion of 
fetus, leading to malformations, anomalies and death; 
(b) severe maternal vlral disease incompatible with normal 
fetal health; and (c) viral infection of the placental 
membranes leading to a defect in maternal-fetal exchange, 
thus interfering with normal fetal development (1,2,4,10�11). 
It is thought that at least 12 viruses are capable of 
causing fetal damage (8,9,12). Although the placenta is 
believed to serve as an impervious barrier to most 
microorganisms, these 12 viruses may result in fetal 
injury, which is apparent either in utero or in the neonate. 
During the first trimester of pregnancy, the developing 
embryo is most susceptible to infection (as particularly 
demonstrated by rubella) when cellular damage can 
seriously impair the embryogenesis of organs and systems. 
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· In the very early stages before organogenesis, death is 
more likely than malformation, though less conspicuous 
defects at the tissue level might also be induced. Thus, 
deviant development can take four forms; death, malfor­
mation, growth retardation, and functional disorder. 
Once the organ or structure has already achieved its 
final form, it may not be susceptible to malformation (4). 
It has been suggested that when the fetus is infected with 
a highly virulent virus, death ensues; whereas, when the 
fetus is infected with a less virulent or attenuated 
virus, the fetus may survive but with impaired normal 
development (10). 
Most of the viruses known to produce teratogenic 
effects either in man or animals are found in five major 
virus groups. Of these, three groups are RNA viruses 
(viz. Myxovirus, Togavirus and Diplornaviruses) and two 
groups are DNA viruses (viz. Herpesvirus and Parvovirus). 
Several viruses in each of the two DNA virus groups 
have been implicated in fetal and neonatal disease. 
Three members of the herpesvirus group (varicella-zoster, 
herpes simplex, and cytomegalovirus) are of clinical 
significance in teratogenesis. Of these three viruses, 
cytomegalovirus produces the most characteristic and 
best described fetal disease. The infection can produce 
microcephaly, hydrocephaly, microphthalmia, chorioretinitis, 
encephalitis, blindness, cerebral calcification, seizures, 
and hepatosplenomegaly in the developing fetus. The 
6 
prognosis for children with generalized infection is poor 
and many are left with neurologic sequelae (e.g. spastic 
diplegia). Congenital infection with cytomegalovirus is 
often not fatal, is frequently subclinical, and persists in 
the infant for months or years (2,8,13,14,15). Knowledge 
of the epidemiology and pathogenesis of congenital cytome­
galovirus infections is very limited, partly due to the 
fact that maternal infections are subclinical. As yet, 
there is no definitive evidence to relate maternal infection 
with the time in pregnancy at which the greatest damage to 
the embryo occurs. 
The teratogenic potential for humans of the other 
DNA group, the Parvoviruses, has not been studied. 
However, four members of this group (Toolan's H-1 virus, 
Kilham's rat virus, Panleucopenia virus, and minute 
virus of mice) have the propensity to attack effectively 
animal fetuses in utero (16). The teratogenic action of 
these virus is based upon their affinity for replicating 
cells (17). Furthermore, there is a close interaction 
between the Parvoviruses and the proliferating vascular 
bed of the developing organism. In the production of birth 
defects, the action of the Parvoviruses (particularly 
minute virus of mice) and rubella is similar (16,18,19). 
Both induce latent and persistent infections, and both 
attack dividing cells and structures such as the fetal 
inner ear. Similar to cytornegalovirus, maternal Parvovirus 
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infection is subclinical with minimum placental involve­
ment, even though there may be severe, widespread, and 
lethal fetal disease (17). 
Minute virus of mice (MVM), first discovered in 
1966 (20), may prove to be on� of the most interesting 
viruses in the study of transplacental viral infections. 
MVM is highly contagious in mice, being transmitted 
mainly by the fecal or urine-oral route. Infection with 
MVM is prevalent in conventional and "specific ·pathogen 
free"mouse breeding colonies, in wild mouse populations, 
and the virus is a common contaminant in pools of mouse 
tumor and leukemia cells (21,22). MVM is more widespread 
in occurrence and induces more benign infections in 
suckling, as well as fetal, animals than either Kilham's rat 
virus or Toolan's H-1 virus (18). Intrauterine infection 
with MVM has been shown to have the capacity to induce 
lethal disease in hamsters, and mild infection in rats 
and mice compatable with fetal survival (14). 
Although MVM appears to be a promising virus for the 
development of an animal model for human fetal infections 
and resultant anomalies, this virus has been one of the 
least studied. A review of the literature reveals only 
one paper concerned with MVM as a teratogen (23). Conclus­
ions drawn from this paper on mouse transplacental studies 
are based upon; (a) maternal in�raperitoneal inoculation 
with analysis of 45 fetuses or neonates from 19 litters, and 
(b) direct fetal inoculations in utero with analysis of 
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four fetuses from two litters (23). Only 16% of pregnant 
mice inoculated were found to have infected fetuses. 
Furthermore, all of these pregnant mice were apparently 
inoculated in the latter part of pregnancy. Thus, no 
studies have been reported to ascertain the effects of 
MVM inoculation at various stages of gestation. From the 
information available, it becomes evident that further 
basic research with MVM is necessary in order to clarify 
the role of this viral infection in fetal and neonatal life. 
Two of the major questions in the area of maternal-fetal 
virology and teratogenesis are; (a) why do only certain 
viruses cross the placenta to produce teratogenic effects, 
and (b) why are many of these teratogenic viruses capable 
of chronic infection (8)? Mims (24) in discussing viral 
teratogenesis has suggested that association of the 
virus with the erythrocyte may be a predisposing factor. 
Kilham's rat virus� Toolan's H-1 virus, lymphocytic 
choriomeningitis, and hog cholera viruses, which are 
teratogenic, are known to be associated with erythrocytes 
(16,17). Demonstration that MVM·is associated with the 
erythrocyte fraction of the blood could provide evidence 
for a common mechanism of transport for these teratogenic 
viruses. 
Not only are the teratogenic effects of MVM poorly 
understood, but minimal data are available as to the 
biological characteristics of this virus that may effect 
its teratogenic potential. The few reported studies 
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on MVM stability have been based upon measuring the 
virus by its hernagglutination activity, which is a 
relatively insensitive method for determining viral 
titers. Studies of actual MVM infectivity for rat 
embryo cells (TCID
50
), following exposures to various 
environmental conditions, have not been reported. 
In regard to the teratogenic RNA viruses the avail­
able evidence appears suggestive that during the first 
trimester of human pregnancy, there is an adverse effect 
of influenza viruses (Myxovirus Group) infection upon the 
central nervous system of the fetus (8,13,14). By compar­
ison, the teratogenic effect of rubella virus (Togavirus 
Group) is well documented in man. 
In animal systems blu.ctongue vir-us and reovlr·us 
(Diplornavirus Group) have been shown to have teratogenic 
effects (2,9)� Bluetongue virus is not known to infect man 
while reovirus is a human pathogen, although it has not been 
associated with human teratogenesis. Colorado tick 
fever (CTF) virus, a human pathogen, shows many charact­
eristics in common with bluetongue and reoviruses. They 
are all non-enveloped, double-stranded RNA viruses of 
the Diplornavirus Group (25,26). However, the viruses 
are not antigenically related and the host range and 
pathogenesis of the agents differ significantly. 
Reovirus infections are common in man, cattle, 
chimpanzees, monkeys, and mice. In 1966 congenital 
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reovirus infection in mice was reported to result in 
teratogenic effects following intraperitoneal inoculation 
at different periods of gestation (27). Twenty-five 
per cent of the offspring demonstrated lassitude, 
retarded growth, and rougheneq fur. Reovirus was isolated 
in high titers, especially from the kidney and lungs. An 
additional 50% of the neonatal mice showed decreased 
spontaneous activity and growth retardation which appeared 
between the 15th and 36th days of life. Viremia was 
present in the remaining 25% of neonatal mice which 
remained clinically well (27). Subsequent experiments 
with reovirus in hamsters, rats, ferrets, and mice have 
demonstrated the production of hydrocephalus in these 
animals following congenital infection (28,29). Blue-
tongue virus has long been known to produce congenital 
malformation and stillbirths in sheep (30). The teratological 
effects of this virus in domestic animals has been well 
studied. How�ver, reported teratogenic studies in 
laboratory animals are minimal, perhaps because of the 
narrow host range of the virus (6,31). 
Colorado tick fever (CTF) virus has not been previously 
reported to cause conienital infections in man or animals. 
The virus is of clinical importance because there are 
several hundred human cases recoghized annually in the 
United States (32). The incidence of Colorado tick fever 
may actually be higher, because frequently physicians 
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mistake Colorado tick fever for Rocky Mountain spotted 
fever (33). Clinically, the disease (CTF) in man is 
usually mild, although it is more sever in children 
than in adults. Two deaths in children have been reported. 
Apparently the virus has an affinity for neural tissue in 
young children since neurological manifestations are 
frequently observed in infections in these individuals (34). 
In the United States the disease is limited to the north­
western area where the wood tick vector, Dermacentor 
andersoni, is distributed. 
An interesting feature of CTF virus is the prolonged 
viremia that is associated with the disease. The 
virus has been detected in human blood for as long as 
135 days and generally produces a viremia of long duration 
in experimentally-infected animals (35,36). The fact 
that CTF virus produces a prolonged viremia and is 
carried within the erythrocyte may be an important 
mechanism in the ability of the virus to produce congenital 
infections. Support for this proposition has been illucidated 
by other workers. 
Mims (24) proposed that viruses circulating free in 
the plasma are rapidly cleared from the blood stream, 
but whenever viruses are associated with red cells, the 
viremia persists for longer periods of time. The form in 
which a virus arrives at placental villi, whether free 
in the plasma or closely bound to erythrocytes, may 
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markedly affect placental infection. A high level of 
viremia with virus free in the plasma may be requisite 
for passage through the placental barrier, while a relat­
ively low vire�ia of erythrocyte associated virus 
persisting over a number of days may suffice (24). Of 
the viruses which have been implicated as inducing 
congenital anomalies (16,17), influenza, Kilham's rat 
virus, Toolan's H-1, lymphocytic choriomeningitis, and 
hog cholera viruses have been known to be associated 
with the erythrocyte. 
Because CTF virus is a Diplornavirus and has been 
shown to be carried within the erythrocyte� investigations 
are warranted to determine possible teratogenic effects 
of CTF virus. Elizan and Fabiyi (9) have ernphasized the 
mass of fragmentary evidence on the role of certain 
viruses as teratogens and stressed the need for carefully 
controlled experiments in which a given virus infection 
is examined critically during progressive stages of fetal 
development. They proposed that there is an obvious need 
for animal model systems to clarify the role of specific 
viral infections occurring in fetal and neonatal life. 
Thus, this research was initiated to determine the 
teratogenic effects of the single stranded DNA minute 
virus of mice (MVM), a pathogen of rodents, and the double 
stranded RNA, Colorado tick fever virus, a pathogen of 
wild animals and humans. Furthermore, basic biological 
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characterization of MVM was performed. This information 
included stability characteristics of MVM, association of 
MVM with erythrocytes, and MVM induction of interferon 
production. 
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MATERIALS AND METHODS 
Viruses 
A virus stock identified as 11MVM antigen strain C.R. 
-10 X CP Lot 7331/16 " was obtained through the courtesy of 
Dr. John C. Parker, Microbiological Associates, Rockville, 
Maryland. For the experimental studies reported here, a 
"working seed n of minute virus of mice (MVM) was prepared 
from infected primary rat embryo cell (REC) culture mono­
layers. Monolayers were infected when the cells were 75% to 
85% confluent and incubated at 37 C. After seven days, the 
cells were removed from vessel surfaces by trypsinization 
and the virus was harvested as a ncell pack antigen n according 
to the method of Schell et al. (37). The cell pack antigen 
was frozen and thawed three times, and treated with ca. 100 
units Of receptor destroying enzyme (Vibrio cholerae -
4Z, Center for Disease Control, Atlanta, Georgia) according 
to the method of Rowe et al. (38) to yield the seed virus, 
which was dispensed and stored in liquid nitrogen. The 
TCID50 (50% tissue culture infectivity dose) was ca. 10
6 ,7/ml 
in secondary rat embryo cells, and the hemagglutinin titer 
was 1:512. Specific MVM antiserum (Microbiological 
Associates) produced in mice was used to identify the seed 
virus by neutralization and hemagglutination procedures (21). 
Stock Colorado tick fever (CTF) virus, identified as ''Florio 
NIH Research reference Reagent #V 506-001-522'', was obtained from 
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the Research Reagents Branch, NIAID, NIH, Bethesda, 
Maryland. Seed virus was prepared by inoculating one-to­
two-day�old suckling mice intracranially, and harvesting 
infected brain tissue when the mice exhibited obvious 
signs of illness. A 10% suspension of infected mouse 
brain was prepared in Wistar minimal essential media (MEM) 
containing 50% fetal calf serum (FCS) according to the 
method of Trent and Scott (39,40). This suspension was 
dispensed in small samples and stored in liquid nitrogen. 
The TCID50 was ca. 10
8 ·7/ml in L929 cells. Specific CTF 
antiserum (Research Reagents Branch, NIAID, NIH, Bethesda, 
Maryland, neutralization index 104 ,5) was used to identify 
the seed virus as CTF virus by neutralization in 1929 
cells. 
GD-7 virus, a mouse picornavirus, was grown in BHK-21 
cells and titered ca. 103,0 hemagglutinin units (HAU)/0.2 ml. 
Vesicular stomatitis virus (VSV), Indiana Strain, was 
acquired from Dr. S. E. Grossberg, Medical College of 
Wisconsin, and was grown in primary chicken embryo cell 
monolayers and titered ca. 2.4 X 108 ·0 plaque forming units 
(PFU)/ml in these cells. 
Animals 
Male, nonpregnant and pregnant female mice (DUB/ICR) 
weighing between 30 and 40 grams and adult mal� and pregnant 
female rats (DUB/SDS) were purchased from Flow Laboratories, 
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Dublin, Virginia. Periodically, animals from the Flow 
Laboratories' colony are serologically tested by Micro­
biological Associates for evidence of MVM infection. All 
colonies tested have been found to be free of this virus. 
In addition, mice were also pretested in our laboratories 
for evidence of MVM infection and were found to be free of 
MVM antibody. CTF virus is not a known contaminant of mouse 
colonies. Therefore, mice were not pretested for evidence of 
CTF virus infection. However, during the cour�e of these 
experiments, non-inoculated control mice were tested for 
evidence of virus and/or CTF antibody and were found to 
be free of evidence of CTF virus infection. 
For purposes of antisera preparation, female white 
�abbits were purchased from a local source. 
Cell cultures 
Rat embryo cells (REC) were prepared from 15 to 18 day 
old decapitated and eviscerated rat embryos. Embryos were 
collected aseptically and minced finely with scissors. The 
minced tissue was transferred to a 300 ml trypsinizing flask, 
on a magnetic stirrer, and washed 15 minutes with 100 ml 
GKN (NaCl, 8.0 gm; KCl, 0.4 gm; glucose, 1.0 gm; deionized 
H2o, q.s. 1000 ml). The supernatant GKN was decanted and 
100 ml of GKN containing 0.1% trypsin (Difeo, 1:250) and 100 ml 
of GKN containing 0.2% methyl cellulose (Fisher, 15 centipoise) 
· were added to the minced material in the trypsinizing flask. 
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The tissue was trypsinized for two hours at room temperature 
(30 C). The cells were then filtered through eight 
layers of sterile gauze into 250 ml centrifuge bottles and 
centrifuged at 65 x g for 15 minutes. The supernatant 
fluid was removed aseptically by aspiration, the cells were 
suspended, transferred to 50 ml graduated centrifuge tubes, 
and centrifuged at 65 x g for 15 minutes. The supernatant 
fluid was again removed by aseptic aspiration. Each 1.0 ml 
of packed cells was resuspended in 10 ml growth medium 
containing 5% dimethyl sulfoxide (DMSO, Fisher Chem. Co.). 
Growth medium (EMEM) consisted of 90 parts Eagle's minimal 
essential medium (Gibco F-15, Grand Island, New York), in 
Earle's balanced salt solution, 10 p�rts heat-inactivated (56 C 
for 30 minutes) FCS, 0.5 parts 7.5% Nairco3, and 200 units of 
penicillin/ml, 100 ug of streptomycin/ml, and 10 ug of 
amphotericin B/ml (Fungizone, E.R. Squibb & Son). The embryo 
cell suspension was distributed and stored in liquid 
nitrogen. To prepare primary rat embryo cell cultures, the 
frozen specimen was thawed quickly and 1.0 to 2.0 ml of 
cell suspension was added to 50 ml of EMEM in a 32 oz. bottle 
and incubated 72 to 96 hours at 37 C. When a confluent 
monolayer had developed, the medium was decanted and 10 ml 
of GKN containing 0.25% trypsin was pipetted onto the cells. 
After one and a half to two minutes, the bottle was then 
agitated to free the cells, 10 ml of growth medium was 
added, and the cells were dispersed by pipetting. A cell 
count was performed by adding 0.5 ml cell suspension to 
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1.0 ml crystal violet-citric acid solution (0.1% crystal 
violet and 1.92% citric acid in water) and counting the cells 
in a hemocytometer. Secondary cultures �ere prepared in 
EMEM and seeded in plastic 24-well trays (Linbro Chemical 
Co., New Haven, Connecticut, 16 mm FB 16-24-TC) with 7 X 105 
cells/ml. Plates were incubated at 37'C in a 2% co2 
atmosphere. 
A stock culture of the continuous line of L929 cells 
was obtained from Microbiological Associates, Inc. The cell 
line was used from the 80th passage to the 110th passage in 
bottle cultures. Growth medium (HMEM) for the L929 cells 
consisted of Eagle's MEM and Hank's balanced salt solution 
(HBSS) (Gibco, F-16), 10% FCS and antibiotics as above. For 
passage, ccnfluc�t monolayers of cells were scraped from 
the vessel surface using a �ubber policeman.'  The cells 
were dispersed by pipetting, and suspended in fresh HMEM. 
Assay cultures were grown at 37 C in a  2% CO2 atmosphere in 
24-well trays seeded with 3 X 105 cells/well. 
For certain interferon assay studies, primary Swiss 
mouse embryo cells (Microbiological Associates, Inc.) were 
grown in plastic 24-well trays seeded with 6 X 105 cells/ml. 
Cells were grown in EMEM with 10% FCS and antibiotics at 
37 C in a  2% co2 atmosphere. 
For a few experiments, Vero, HeLa, BHK-21, XC rat cells, 
and WI-38 cell lines, obtained from the American Type 
Culture Collection, Rockville, Maryland, were employed. 
The Vero, HeLa, XC rat cells, and WI-38 cells were grown in 
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EMEM with 10% FCS, 10% tryptose phosphate broth (Difeo) 
and antibiotics. These cell lines were grown at 37 c in a 
2% CO2 atmosphere. 
Viral assays in cell cultures 
Assays for MVM were determined by the cytopathic effects 
(CPE) in REC culture according to the methods of Parker (21). 
Briefly, growth medium was removed from 75 to 85% confluent 
secondary REC monolayers, ten-fold dilutions of virus were 
made in EMEM, and four wells of cells were inoculated with 
0.1 ml each of the appropriate dilution. For controls 
appropriate wells were inoculated with virus diluent only. 
Preliminary experiments demonstrated that optimal adsorption 
time for MVM was two hours. Ther·efore, the inocuium was 
left in contact with the cells for two hours at 37 C. The 
cells were thert washed twice with 1.0 ml of HBSS, and 
finally 1.0 ml of Wistar EMEM containing 2% FCS and 
antibiotics was added. All viral dilutions and inoculations 
of cell cultures were done in a Sterilgard Baker Biological 
Hood (The Baker Co. Inc. Sanford, Maine). Cells were 
observed microscopically for MVM CPE daily for 12 days. 
Cell infection was reported on the basis of Oto 4 + scale 
by microscopic examination (i.e. 0 = no evidence of viral 
infection, 1 + = 20% to 50% of cells affected, 2 + = greater 
than 50% of cells affected, 3 + = beginning of cell sheet 
destruction, and 4 + = massive cell sheet destruction). 
Characteristic CPE of MVM is evidenced by rounding up of 
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REC with darkened and rounded nuclei. Wells showing 2 + 
or greater CPE were used to calculate the virus titer 
(TCID50) by the Reed-Muench method (41). 
Assays for CTF virus were determined by CPE in L929 
cells according to the method of Trent and Scott (40). 
Briefly, confluent monolayers of L929 cells were grown in 
HMEM in 24-well plastic trays. For inoculations growth 
medium was removed from the cells, ten fold dilutions of 
virus were made in HMEM, and 0.1 ml of the appropriate 
dilution of virus was inoculated into each of four wells. 
Virus was allowed to adsorb for one to two hours at 37 C 
in 2% CO2 atmosphere. Then 1.0 ml of Wistar MEM containing 
2% FCS and antibiotics was added and the cultures were 
observed daily for five to seven days. CPE was recorded 
on a Oto 4 + basis and the virus titer determined as 
noted for MVM. 
Hemagglutination assays 
In MVM studies, the "cell pack antigen" was assayed 
for hemagglutinin content. The antigen was diluted in 
phosphate buffered saline bovine albumin (Armour, Chicago, 
Illinois), pH 7,3 (PBS-BA). The PBS-BA consisted of 
NaCl, 8.5 g; Na2HPO4, 0.565 g; KH2PO4, 0.135 g; bovine 
albumin V, 2.5 g; deionized H20, q.s. 1000 ml. Locally 
obtained guinea pig red blood cells (GP RBC) were washed 
initially three times for 10 minutes in 0.15 N NaCl and 
finally once for 10 minutes in PBS-BA. A suspension of 
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GP RBC was made in PBS-BA. For hemagglutinatlon studies, 
the microtiter system was used (42). Antigen dilutions 
were made from 1:2 to 1:2056 in 0.05 ml of PBS-BA. Finally, 
0.05 ml of the lJ GP RBC was added to each well and the 
mixtures incubated for about one hour at room temperature. 
The results of the hemagglutination were interpreted using 
the "tear drop" method (21). 
For GD-7 virus hemagglutination assays, the antigen 
consisted of infected cell culture fluids and t·he method 
of Oie et al. was used (43). Human red blood cells (HuRBC), 
type 0+ were'obtained from the Blood Bank of the Medical 
College of Virginia. Cells were washed in 0.15 N NaCl as 
indicated above. Antigen dilutions were made from 1:2 
to 1:2056 in 0.2 ml of 0.15 N NaCl in plastic plates 
(Linbro, disposable trays # 96 SC). Then 0.2 ml of a 
0.5% suspension of HuRBC in saline was added to each well. 
Plates were incubated at 4 C for 24 hours. The virus 
hemagglutinin titer was determined as the highest dilution 
yielding complete agglutination of the HuRBC. 
Serologi6al studies 
The hemagglutination inhibition (HAI) test was performed 
in the microtiter system to identify the virus as MVM and to 
determine the presence of antibodies to MVM in experimental 
animals. All antisera and test �amples were treated with 
approximately 100 units of receptor destroying enzyme before 
assay. In both types of studies, 0.025 ml of PBS-BA was 
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placed in each microtiter well and 0.025 ml of a 1:10 
dilution of MVM known antisera, or test sample (serum or 
in some cases 50% organ· supernatant material) was added 
to the first well. The sera were then diluted from 1:20 
and to 1:40960. Eight HA units of MVM in 0.025 ml of 
diluent was added to each well and the virus-serum mixture 
was incubated for one .hour at room temperature. A 1% 
GP RBC suspension in PBS-BA (0.05 ml) was added to each 
well and the titer was read in one to one and a half hours 
at room temperature using the "tear drop" method. 
In these virus identification studies, three different 
antisera were used: commercial MVM specific antisera from 
Microbiological Associates, and male rat and female rabbit 
antisera prepared in our laboratory. Rats were inoculated 
intraperitoneally with 106 ,7 TCID50 of MVM on days one, 
eight, and fifteen. On day 22, the rats were anesthetized 
and exsanguinated by cardiac puncture. The rabbits were 
inoculated with 105 ·7 TCID50 of MVM in each foot pad 
(intradermal) on day one, and eight. On the 15th day the 
rabbits were inoculated with 106 ,7 TCID50 MVM intravenously, 
and on the 22nd day, rabbits were anesthetized and 
exsanguinated by cardiac puncture. 
For the identification of CTF virus, both in vivo 
and in vitro virus neutralization studies were done. In 
the in vitro system, ten fold dilutions of seed virus from 
10-3 to 10-9 were prepared in HMEM with 10% FCS and antibio­
tics. To 0.25 ml of each dilution, 0.25 ml of specific 
CTF antisera was added and the mixture was incubated for 
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one hour in a 37 C water bath. One tenth ml of the virus­
serum mixture was inoculated into each of four wells with 
1929 cells and incubated at 37C for seven days. For a 
control, 0.1 ml of each virus dilution in HMEM was inoculated 
similarly. 
In in vivo neutralization studies, a single dilution of 
CTF virus was used. Equal parts of undiluted antisera and 
a dilution of seed virus were mixed to give a final 
concentration of 104 ·3 TCID5o/ml of virus. The. mixture 
was incubated for one hour in a 37 C water bath and pregnant 
mice were inoculated intraperitoneally with 0.1 ml of this 
mixture. Pregnant mice were observed for abortions, 
stillborns� and neonatal deaths. 
For CTF virus antibody assays irt in vitro virus 
neutralization test was performed. For these studies, 
approximately 100 TCID50/ml of virus were mixed with 
equal portions of test serum or in some cases, the 
supernatant fraction of 50% organ tissue suspensions. 
Virus serum mixtures were incubated and inoculated onto 
cell cultures as previously described. 
Characterization of MVM stability 
For chemical inactivation, a 1:10 dilution of the 
working seed MVM preparation was made in the test chemical 
agents. The chemicals tested included 95% and 70% ethanol, 
99% isopropanol, 1.0% and 0.5% formaldehyde, 5.25% sodium 
pypochlorite, chloroform and 2% glutaraldehyde. The source 
and purity of the sto6k chemicals is shown in Table l; 
TABLE 1. Source and pur1ty of chemicals for minute virus 
of mice inactivation 
Chemical Source & Purity 
Glutt�iJdehyde (Cidex) 
Formaldehyde Solution 
(37.2% HCHO) 
Sodium Hypochlorite 
(5.25%) 
Ethanol 
Isopropanol (99%) 
Chloroform 
Hydrochloric Acid 
Arbrook, Arlington, Texas 
Fisher, C�rtified A.C.S. with 
12 - 15% methanol as a 
preservative 
Blue Magic co·., Wilson, North 
Carolina nModern _Age Bleach" 
Goldshield U.S.P. Alcohol, 
New Jersey 
Haskel Corp., Richmond, Virginia 
Mallinckrodt, New York, U.S.P. 
Fischer. Certified. 
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When necessary to achieve the desired dilution, concentrated 
chemicals were diluted in deionized water. 
For acid inactivation, samples of one ml of the working 
seed MVM were placed in sterile 1/4" dialysis tubing and 
dialyzed against 0.15 N KCl-HCl solution at pH 2.0 at 
4 C for 11 days. Samples were taken at various days and 
the pH was adjusted by dialysis against HBSS containing 
0.02M-sodium phosphite, pH 7.2 , prior to assay. 
For temperature inactivation,1.0 ml samples of the 
working seed MVM were placed in 12 X 75 polypropylene 
tubes. and we�e subjected to various temperatures: -196 C 
(liquid nitrogen freezer); 4 C (refrigerator); 35 C, 45 C, 
and 60 C (water bath); and 100 C (boiling water). The time 
periods for test analysis were from initial exposure and not 
from the point at which temperature of samples first reached 
that temperature. 
For inactivation with ultraviolet (UV) light, 1.0 ml 
samples of MVM were placed in a 100 X 15 mm open plastic 
petri dish which was placed on a rocker platform. A General 
Electric UV germicidal lamp (principal emission 254 nm) 
was used to deliver varying doses of ultraviolet light 
with an average dose rate of 20 ergs/mm2 /sec as measured 
by a dose-response meter (Blak-Ray Ultraviolet Products Inc. 
model #J2 2 5, San Gabriel, California). Doses delivered 
were between 100 and 500 ergs. The control growth medium was 
exposed to 500 ergs. 
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At the completion of the select.ed treatments, individual 
samples were assayed to determine the remaining titer of 
MVM. 
Association of MVM with mouse erythrocytes 
Adult male, nonpregnant female and pregnant 
mice were bled and their sera tested by HAI to ensure the 
absence of MVM antibodies. Hematocrits were performed upon 
each group of mice. These mice were then inoculated 
intraperitoneally with 10.5-5 TCID
50
/ml of MVM. The groups 
of mice were bled daily via the retroorbital plexus using 
sterile capillary pipettes, freshly rinsed with heparin 
(sodium heparin 1000 U.S.P. units/ml Upjohn Company, 
Kalamazoo, Michigan). Blood from five mice was pooled in 
6 X 25 mm tubes and centrifuged at 4 C for 10 minutes at 
300 X g. The plasma was collected aseptically, the buffy 
coat was discarded, and the erythrocyte fraction washed 
three times with 100% FCS. After each wash, 10% of the 
upper layer of erythrocytes was discarded. After the 
third wash, the bottom layer of erythrocytes was stored 
in liquid nitrogen as was the plasma fraction. Dilutions 
of the thawed samples, with control�, were inoculated onto 
secondary REC for viral assay. 
Interferon (IF) studies with MVM 
Plasma samples from J\1VM-infected mice were assayed 
for IF by measuring yield reduction of GD-7 virus in L929 cells. 
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The method was essentially that of Oie et al. (43). Briefly, 
when the L929 cells, (seeded at 3.5 X 105 cells/ml) were 
a confluent monolayer the cells were inoculated with two­
fold dilutions of the plasma samples (day 1 through day 10) 
of the male, female-pregnant and nonpregnant mice. Dilutions 
of the plasma sample were made from 1:10 to 1:25,920 in 
maintenance medium (HMEM with 2% FCS and antibiotics). A 
variation from Oie et al. (43) was that duplicate tube 
cultures were each incubated with 0.5 or 1.0 ml of the 
sample dilution. After 18-20 hours· of incubation at 37 C, 
the cultures were washed twice with HBSS and challenged 
with GD-7 virus. After three hours incubation (37 C), the 
cultures were washed twice with HBSS and fed with Wistar 
MEM containing 2% FCS and antibiotics. Controls included a 
known mouse serum IF, GD-7 virus, normal mouse p1asma, and 
uninoculated cells. The control mouse serum interferon 
was obtained through the courtesy of Dr. Page Morahan, 
Virginia Commonwealth University. After an overnight 
incubation at 37 C, replicate cultures were frozen, 
thawed, the resultant fluids were pooled, and the HA 
assay was done. The titer of an IF preparation was 
calculated as the reciprocal of the highest dilution of IF 
producing 0.5 log reduction in HA yield. All values were 
corrected to the simultaneously assayed standard murine IF 
which titered 40,000 ± 4,000 standard error. 
To determine MVM sensitivity to IF, the standard 
mouse IF was incubated on four wells of rapidly growing 
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secondary mouse embryo cells for 18-24 hours. The cultures 
were washed twice with HESS and challenged with 0.1 ml of 
either 104 TCID50 of MVM or 10
4 TCID50 Of VSV. Controls 
included titrations of MVM and VSV in mouse embryo cells 
and uninoculated cells. After a two hour viral adsorption, 
the cultures were fed with 1.0 ml of Wistar MEM containing 
2% FCS and antibiotics. The titer of the control VSV was 
determined by the CPE �n mouse embryo cells. The titer of 
IF against VSV was calculated as the reciprocal of the 
highest dilution which resulted in 50% reduction in CPE. 
Characteristic CPE was not clear with MVM so that a MVM 
yield reduction assay was performed. After seven days 
incubation, cultures were frozen and thawed three times, 
replicate fluid suspensions were pooled, and MVM growtl� 
yields were titrated in secondary REC. 
Teratogenic studies 
A total of 195 timed pregnant mice were used in 
experiments designed to determine the teratogenic effects of 
CTF virus and MVM. rrhe number of mice used at each ge-stational 
period and the dose and route of inoculation for each virus 
and controls are shown in Table 2. In all, four separate 
experiments were performed. Because CTF virus has not been 
reported previously to be a teratogen, when teratogenic 
effects were initially demonstrated with the virus, more exten­
sive experiments were conducted, including neutralization 
studies, to prove that this teratogenic effect was due to the 
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TABLE 2 Utilization of mice in teratogenic studies 
Inoculum* Number of mice per week of gestations 
Material 
'l'CID50 
- Route 1st Week 2nd Week 3rd Week Totals - Dose 
CTF 106.3 IU 15 
CTF 106.3 IP 20 20 14 
CTF 104.3 IP 5 2 
CTF 104.3 
IP 12 6 
CTF antisera 
CTF 104.3 
IP 5 2 
Normal sera 
MVM 105.0 IU 15 
. MVM 105.0 IP 15 15 5-
Di.luent IP 5 5 5 
Uninoculated 10 11 8 
Totals 50 73 72 
*CTF= Colorado tick fever virus, MVM= minute virus of mice, 
IU= intrauterine, and IP= intraperitoneal. 
15 
54 
7 
18 
15 
35 
15 
29 
195 
30 
virus. 
In order to investigate the mechanism by which CTF virus 
and MVM produce their effects, several virus-inoculated 
and control pregnant mice were sacrified at random during 
the last one to three days of gestation. Maternal tissues, 
placenta, and embryos were collected for viral assays. 
Mice inoculated during the second or third week of gestation 
were utilized in these studies. The selected mouse was 
lightly anesthetized with ether and exsanguinated by 
cardiac puncture. The abdomen was disinfected with 70% ethanol 
and aseptically incised along the midline. The gravid 
uterus was aseptically removed, placed in a sterile petri 
dish, and washed twice in HBSS. Utilizing sterile scissors 
and forceps, the uterus was carefully opened, and each fetus 
with its placental membranes was removed and placed in a 
separate petri dish. Embryos were then removed aseptically 
and washed thoroughly in HBSS. Placental membranes from each 
uterus were pooled. Fetuses were stored individually. The 
uterus was inspected for number of embryos in the litter and 
evidence of fetal abnormalities and reabsorption. Maternal 
sera, maternal erythrocytes, and maternal long bones and 
organs (spleen, liver, kidneys) were collected from 
sacrificed mothers individually. All samples were stored 
at -70 C for viral assays. 
The delivered mice were examined for total numbers in 
the litter (noting liveborn or stillborn� other gross 
anomalies at birth, and developmental anomalies (e.g. alopecia, 
runting, cataracts, and signs of acute viral infection) over 
a six week period. Neonatal deaths were recorded in periods 
of time from delivery (days 1-9, 10-19, 20-29). When the 
post mortem specimens were suitable for examination, dead 
mice were collected, labeled, and frozen at -70 C for viral 
assays. In addition, grossly "normal" neonates randomly 
selected over the six week period were sacrificed by 
cervical dislocation and frozen at -70 C for later studies. 
In two experiments, each litter, including controls, 
was reduced to a constant number of eight mice at delivery. 
In these experiments, each neonatal mouse was weighed at 
delivery and weekly for six weeks. Over the six week 
period, the litter was reduced to six mice at one week, 
to four mice at two weeks, and to two mice at three or 
four weeks. In these mice surviving three to four weeks, 
antibody titers to CTF virus or MVM were determined. 
To determine the presence of virus, all frozen solid 
tissue samples were triturated using mortar and pestles with 
alundum and the appropriate diluent. The diluent for all 
MVM samples was EMEM with 10% FCS and antibiotics: .the 
diluent for CTF virus samples was HMEM with 50% FCS and 
antibiotics. Whole fetuses were triturated to yield 50% 
suspensions. Pools of long bones, spleen, kidney and liver 
from maternal mice, delivered mice, neonatal dead mice, and 
randomly selected normal mice were triturated into 10% 
or 50% suspensions. These suspensions, along with maternal 
erythrocyte and serum specimens, were tested for th� 
presence of MVM in REC or CTF virus in 1929 cells. 
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Statistics 
In cooperation with the Biometry Department, Medical 
College of Virginia, all suitable data (e.g. weight gains, 
incidence of stillbirths, incidence of neonatal deaths) 
were analyzed statistically. The following standard 
statistical techniques were used to analyze the data: 
contingency table analysis, analysis of variance, and simple 
linear regression. 
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RESULTS 
Identification of viruses 
For identification of minute virus of mice (MVM), 
dilutions of the antisera prepared in our laboratory and 
commerically obtained MVM specific antiserum were tested 
against four to eight hemagglutinin units (HAU) of "working 
seed" MVM. MVM was inhibited by rat antisera at a dilution 
of 1:640 to 1:128 0; by rabbit antisera at a dilution of 1:5120 
to 1:10,240; and by commercial MVM. antisera at a dilution of 
1:10,240. 
For identification of Colorado tick fever (CTF) virus, 
the "working seed" CTF virus (titer ca. 108 -7 TCID
50
/ml) was 
subjected to virus neutralization studies with specific 
antisera obtained from Research Reagents Branch N.I.H. The 
titer of CTF virus was reduced by 104 ·0 TCID /ml in L929 
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cells following neutralization. 
The results confirmed that the initial virus stocks 
agreed with accepted reference criteria. 
Growth of MVM in various cell lines 
Because of the difficulties involved in preparing and 
culturing primary and secondary rat embryo cultures (REC), 
preliminary studies were undertaken to attempt to find another 
cell system in which MVM infectivity could be demonstrated by 
CPE (Table 3). The maximal MVM infectivity titer (10 3 -7 Tcro
50
tml) 
obtained in non REC cultures was with WI 38 cells. L929 cells 
TABLE 3. 
Cell lines 
WI38 
L929 
BHK-21 
HeLa 
Vero 
XC 
REC 
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Titration of minute virus of mice in different 
cell lines 
Description 
Human lung 
Mouse fibroblast 
Syrian baby hamster 
kidney 
Human cervical 
carcinoma 
African green monkey 
kidney 
Wistar rat tumor 
induced with 
Rous sarcoma virus, 
Prague strain 
Secondary DUB/SDS rat 
embryo cells 
Titer (TCID50/ml) 
�100.5 
6100.5 
!fl00.5 
�100.5 
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were the only other cell line in which MVM CPE was demon­
strated (titer 101 -3 TCID50/ml). Infected BHK-21 cells 
were altered slightly with loss of some cells; however, the 
minimal CPE seen were not sufficiently distinct for reliable 
evaluation. In none of the cell lines did MVM produce as 
· 6 7 characteristic CPE nor as high an infectivity titer (ca. 10 · 
Tcro50/ml) as in primary or secondary REC. Therefore, REC were 
used for the experiments in the research concerning MVM. 
Inactivation of MVM by chemicals, temperature, and ultraviolet 
radiation 
Only limited published information is available concerning 
the lability of MVM to chemical and physical inactivators. 
Because such information could be useful in disinfecting 
contaminated materials and in preparing vaccines, the suscept­
ibility of MVM to various chemicals, pH 2.0, UV radiation, 
and heat were determined. All the chemicals tested were 
effective inactivators of MVM infectivity under the conditions 
used. In controlled studies, the chemicals tested were not toxic 
for REC except where noted. While the control MVM titer was 
106.7 TC1O50;m1, there was no detectable MVM immediately 
following exposure of a 1:10 dilution of virus to any of the 
chemicals (Table 4). Chloroform and sodium hypochlorite 
were toxic to REC at the lowest dilution used ( 1 :10 MVM-chemical 
mixture), although the excess chemicals were washed off the 
cells two hours after inoculation·. Thus, these two chemicals 
could only be shown to reduce the viral titer by 10 4 ·7 TCID50/ml. 
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TABLE 4. Inactivation of minute virus of mice (MVM) by 
selected chemicals * 
Reduction of 
Chemical Concentration titer from control** 
(TCID/ml) 
Ethanol 95% � 105-7 
Ethanol 70% � 105-7 
Isopropanol 99% ::!: 105-7 
Formaldehyde 1.0% :!: 105-7 
Formaldehyde 0.5% � 105-7 
Gluteraldehyde (Cidex) 2.0% :?: 105-7 
Sodium Hypochlorite 5.25% � 104.7 -I 
Chloroform undiluted � 104.7 -I 
* One part of working stock virus was mixed with nine parts 
of the indicated chemical and immediately assayed for virus 
content in REC. 
** Control MVM titer = 10 6 ·7 TCID50
/ml in REC. 
Chemical was toxic for REC at 1:10 dilution. Therefore, a 
1:100 dilution was the initial dilution tested. At this 
dilution, there was no toxicity for the REC. 
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Acid treatment of MVM with 0.15 N KCl-HCl solution at pH 
2.0 decreased the initial viral titer (expressed as TCID50/ml) 
of 106 -7 to 104 -3 in one day, to 10
4
·0 in two days, to 103 ·5 
in four days, an� to 10
1
·3 in seven days. By 11 days there 
was no detectable MVM infectivi�y (Figure la). When these 
data were plotted by percent survival, it can be seen that 
98% of MVM infectivity was inactivated in one day. Ten 
additional days of acid treatment were necessary to eliminate 
the remaining low levels of MVM infectivity (Figure lb). 
MVM was also found to be heat sensitive. The control 
MVM titered 10 6 ·7 TCID50/ml in these studies. When MVM was 
heated at 100 C, for 15 minutes, the titer decreased to �10°-5 
TCID50;ml. When MVM was heated at 60 C, for 60 minutes, the 
titer decreased to 102 ·6 TCID
50
;ml. At 45 C, MVM was 
unaffected for 20 minutes, and after a total of 120 minutes 
exposure at 4 5 C the titer was 103 ,7 TCID50/ml. At 35 C, 
MVM remained stable for one hour; then the titer gradually 
decreased to 105-6 TCrn50ml at the end of 220 minutes (Figure 
2a). When these data were plotted by percent survival, it 
could be seen that the inactivation of MVM was greater than 
95% within 60 minutes at 100 c, 60-C, and L15 C. However, 
180 minutes were required to inactivate 90% of MVM at 35 C. 
Perhaps of more importance, at temperatures of l15 C and 60 C, 
there appeared to be a themoduric fraction of MVM infectivity 
(Figure 2b ) . 
MVM was more stable at refrigerator and freezer temper­
atures. At 4 C, over a ten week period, there was a loss of 
virus titer of 4.3 log10 (Fig�re 3a). On a percent survival 
38a 
FIG. 1. Acid inactivation of minute virus of mice. 
Expressed as the log10 TCID50
/ml in A and as virus 
survival (%) in B. MVM in EMEM with 10% FCS and anti­
biotics was dialyzed �gainst 0.15 N KCl-HCl solution at 
pH 2.0 at 4 C for 11 days. At intervals, samples were 
removed and the pH adjusted to pH 7.2 by dialysis against 
HBSS containing 0.02 M sodium phosphite. The adjusted 
samples were titrated on secondary REC. 
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FIG. 2. Heat inactivation of minute virus of mice. 
Expressed as log10 TCro50/ml in A and as virus survival 
(%) in B. MVM in EMEM with 10% FCS and antibiotics was 
placed in 12 X 75 polypropylene tubes and heated at the 
indicated temperature�. At intervals, samples were 
removed and titrated on secondary REC. 
Legend. 0---0 35 C 
6---,,/2 4 5 C 
e---0 60 C 
&--A 100 C 
_J 
' 
It) 
g 4 
0 
c.9-
g 2 
39 
"" 
I 
l 
20 40 60 80 100 i20 140 160 1-80 200 220 
t\,';L ,/LJ"i1 • ;�·t,.: i·1,�Y ·-' . e-V 
FIG. 8 
0 0 
8--'\ 
--- ��!·�-:-:t- - �--,---
20 40 60 80 100 120 140 iB0 180 200 220 
HNUTES 
40a 
FIG. 3. Stability of minute .virus of mice at 4 C and at 
-196 C. Expressed as the log10 TCID50/ml in A and as virus 
survival (%) in B. MVM in EMEM with 10% FCS and anti­
biotics was placed in 12 X 75 polypropylene tubes and 
stored at 4 Cin a household refrigerator or in a liquid 
nitrogen freezer. At intervals, samples were removed and 
titrated on secondary REC. 
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basis, 50% of MVM infectivity persisted at one week, 1 3% 
at four weeks, and 0.5% at ten weeks (Figure 3b). After 
nine months storage in liquid nitrogen (ca. - 196 C) there 
was no loss of MVM infectivity for REC. 
With ultraviolet (UV) light, the MVM TCID50/ml titer 
decreased from 107 - 25 to 105 -6 with 100 ergs/mm2 to 104 · 5 
with 200 ergs/mm2 to 104 ·0 with 300 ergs/mm2 to 103.0 with 
4 00 ergs/mm2, and to 101 -3 with 500 ergs/mm2 (Figure 4a). 
Expressed as percent survival, 100 ergs/mm2 inactivated 98% 
of MVM infectivity; whereas, an increased UV dosage up to 
500 ergs/mm2 was necessary to effectively inactivate the 2% 
residual virus (Figure 4b). The rate of UV inactivation was 
1.2 log10;100 ergs. 
Thus, all of the chemicals used and boiling temperatures 
completely inactivated all detectable virus within a few 
minutes; while temperatures of 35 C, 45 C, and 60 C, pH 2.0, 
and UV radiation inactivated more than 90% of detectable 
virus within a short time, but invariably left a "persistent" 
fraction of virus which was difficult to inactivate. 
Association of MVM with mouse erythrocytes and interferon 
studies 
Because many teratog�nic viruses are known to be found 
in association with erythrocytes in the infected animal, 
studies were undertaken to determine if this phenomeon was 
also characteristic of MVM. Prior to studies on the assoc­
iation of MVM with erythrocytes, all mice were bled, 
42a 
FIG. 4. Ultraviolet radiation inactivation of minute 
virus of mice. Expressed as the log10 TCID50
/ml in A 
and as virus survival (%) in B. MVM in EMEM with 10% FCS 
and antibiotics was placed in 100 X 15 mm open petri 
dishes on a platform rocker. Varying doses of ultra­
violet radiation were delivered to the samples. The 
samples were titrated on secondary REC. 
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hematocrits performed, and sera tested for antibodies to 
MVM. Serum samples were negative for MVM antibodies by the 
HAI test. The average hematocrit of the nonpregnant and 
pregnant female mice was 42% (range 40-45%) as compared to 
47% (range 45 -49%) for the males. After the mice has been 
inoculated intraperitoneally with 105 ·5 TCID
50 of MVM, the 
erythrocyte fractions of the three groups of mice all 
showed evidence of MVM infectivity, when the erythrocytes 
were subcultured in REC (Figure 5). Erythrocyte fractions 
consisted of pools of five mice in each group. The peak 
erythrocyte viremia in infected animals was noted between 
four and seven days subsequent to MVM inoculation. The 
peak titers obtained with pregnant and nonpregnant females 
were identical (104 -75 TCID
50/ml) only being slightly 
altered in time sequence (one day). The peak erythrocyte 
viremia titers (107 ,0 TCID50/ml) for male mice were 
significantly higher (p<0.01) than those corresponding 
titers obtained from female animals. During the 10 day period, 
MVM could not be detected in the plasma fractions of the 
blood. 
Because the role of interferon (IF) has not been 
established in MVM infections, MVM �as studied to determine 
if it is an inducer of IF, or if it is sensitive to IF. 
For IF induction studies, plasma fractions of MVM 
inoculated mice were assayed for the presence of IF. MVM 
induced IF at a low magnitude as seen in the results given 
in Table 5. Interferon was not detected, at the lowest 
44 a. 
Fig. 5. Association of mj_nute virus of mice (MVM) with 
mouse erythrocytes. Following intraperitoneal inoculation 
of 105 -5 TCID
50 
of MVM, groups of mice were bled via the 
retroorbital plexus. Heparinized blood samples were 
centrifuged, the erythrocyte fraction collected and washed 
three times with 100% FCS. Plasma and washed erythrocytes 
were frozen and thawed prior to titration on secondary 
REC. The results are expressed as the log10 TCID5 0/ml. 
Legend. 0--- --0 Erythrocytes (male) 
[-J--.-.0 Erythrocytes (female) 
6c-- -6 Erythrocytes (pregnant) 
o---Q Plasma (male, female 
and pregnant) 
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TABLE 5. Interferon titers of plasma obtained from mice 
following inoculation with minute virus of 
mice (MVM) 
Day* Male Nonpregnant female Pregnant female 
1 6 4 5** f 18 � 20 
2 !:: 45 34 � 20 
3 � 45 40 � 20 
4 f 45 f 18 f 20 
5 f 45 f: 18 � 20 
6 � � 5 f 18 f: 20 
7 ' 45 � 18 42 
8 � 4 5 f: 18 5 6 
9 f 45 16 42 
10 6 45 16 f 10 
* Days following inoculation of mice with 105 , 5 TCID
50 of MVM. 
*� Interferon titer = Reciprocal of greatest plasma dil-
ution resulting in 0. 5 log10 reduction of GD-7 virus 
hemagglutinin yield. Values were adjusted to a 
standard interferon preparation assayed simultaneously. 
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dilution tested in the male mice during the 10 day period. 
In nonpregnant female mice, IF titers were low, ranging from 
16 to 40 units. In pregnant mice, IF titers ranged from 
less than 20 units on all days, except titers of 42, 56, and 
42 units were detected on days 7, 8 and 9 respectively. 
MVM appeared to be a weak inducer of IF. Experiments 
were then performed to determine the sensitivity to IF of 
MVM in comparison to vesicular stomatitis virus (VSV), a 
virus known to be quite sensitive to IF ( 4 4). In these 
studies a known standard for mouse IF was used. The standard 
mouse IF, at a dilution of 1:960, inhibited 50% of VSV CPE 
in mouse embryo cells. In similar experiments, mouse 
embryo cells were treated with dilutions of IF and infected 
with 10
4
·2 TCID50 of MVM. Inoculated. cells wer·e examiueu 
daily for evidence of viral induced CPE; however, the CPE 
evidence was not conclusive. Therefore, in an effort to 
determine the titer of MVM in the IF treated cell cultures, 
the cells were frozen and thawed three times and assayed 
for HA. These results were also negative. Finally, the 
infected cell cultures at each IF dilution were individually 
titrated on REC. In this manner, the yield of MVM virus 
in the presence of IF was determined. The results revealed 
that the standard mouse IF reduced the virus yield signif­
icantly (0.5 log10) at a dilution of 1:22,000. 
Teratogenic studies with MVM 
MVM has been reported to cross the placenta and produce 
teratogenic effects in mice; however, detailed studies have 
not been reported (23). Therefore, studies were undertaken 
to add to the available information concerning MVM terato-
genesis in this host. "Timed pregnant" mice were obtained 
commercially for these studies. As can be seen in Table 6, 
a large number of these mice, both virus inoculated and 
controls, failed to deliver, indicating that many of these mice 
were actually not pregnant. 
Parturition data for mice born of mothers inoculated 
with MVM are given in Table 6. The stillbirth incidence in 
mice born to intrauterine (IU) inoculated mothers during 
the third week of gestation is significantly increased over 
the controls (p<0.01). There were no other stillbirths in 
any of the other MVM groups. The neonatal mortality data 
were more indicative than the stillborns data, of the 
teratogenic effect of MVM (Table 7). Intrauterine inoc­
ulation of MVM during the third week of gestation did not 
result in a significant increase in the incidence of neonatal 
deaths as compared to the controls (p�0.05). Intraperitoneal 
(IP) inoculation with MVM during the first, second, or 
third week of gestation did result in a significant increase 
in neonatal deaths as compared to the controls (p-<'.'..0.05 for 
the third week and p<0.01 for the first and second weeks). 
Uninoculated and diluent controls were not statistically 
different and were pooled for comparative analysis. 
To determine the percentage of fetuses with infectious 
MVM, maternal mice were sacrificed at 18 to 20 days of 
TABLE ·6. Parturition data for mice inoculated with minute virus of mice 
Inoculum Total mice Livebirths Stillbirths 
Week of Dose ·Average 
gestation TCID
50 
Route* Inoculated/Delivered Total litter Total 
-
Third 105.0 IU 15/10 (+3)** 94 9.4 5 5 
105.0 IP 5/4 42 10 0 0 
Diluent I- IU 5/3 (+l) 35 12 0 0 
Uninoculated - 8/8 96 12 0 0 
Second 105.0 IP 15/7 (+2) 76 11 0 0 
Diluent IP 5/3 26 9 0 0 
Uninoculated - 11/4 . ( +l) 37 9 0 0 
First 105.0 IP 15/1 9 9 0 0 
Diluent IP 5/0 Q - 0 
Unincculated - 10/1 9 9 0 0 
* IU = Intrauterine, IP = Intraperitoneal. 
** Number of litters sacrificed between day 18-20 of pregnancy. 
I- EMEM with 10% FCS and antibiotics. 
TABLE 7. Incidence of neonatal mouse mortality following fuaternal inoculation with 
minute virus of mice 
Number of neonatal 
Inoculum mice studies Neonatal deaths 
Week of Dose Days postoartum 
gestation TCID50 Route* 0-9, 10-19, 20-29 Total % 
Third 105,0 IU 80 7 1 2 10 12.5 
105,0 IP 32 6 0 0 6 19.0 
Diluent** IU 24 1 0 0 1 4 
Uninoculated - 50 5 0 0 5 6 
Second 105.0 IP 56 10 1 0 11 20.0 
Diluent IP 16 1 2 0 3 18 
Uninoculated - 34 2 0 · O 2 4 
First 105,0 IP 8 2 0 0 2 25 
Uninoculated - 8 0 1 0 1 12 
* IU = Intrauterine, IP = Intraperitoneal. 
** EMEM with 10% FCS and antibiotics. 
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gestation and the fetuses removed. Maternal mice were inoc­
ulated IU during the third week and IP during the second week 
of gestation with 10 5 ,0 TCID50 of MVM. There was no evidence 
of fetal reabsorption nor blighted embryos. Individual 
fetuses were triturated and the resultant suspensions were 
assayed for the presence of virus. Of the fetuses obtained 
from mothers inoculated IU, 77% had detectable MVM. Of 
those fetuses obtained from mothers inoculated IP during the 
�econd week of gestation, 91% had detectable MVM. None of the 
controls had detectable virus (Table 8). 
In order, to determine whether virus persisted after 
birth, neonates were randomly selected at delivery and at weekly 
intervals thereafter, and assayed for the presence of MVM. 
An overall total cf 30% of the s11rvivors test0d had detectable 
MVM (Table 9). The greatest incidence of detectable MVM 
occurred in the group of neonates whose mothers had been inocul­
ated during the second week of gestation. Ten of the litter­
mates of mice inoculated IP during the second week of gest­
ation were bled at six weeks of age and their sera assayed for 
antibody using the HAI test. None of the ten mice tested had 
evidence of MVM antibody at six weeks of age. 
In addition to mortality, virological, and serological 
studies, neonates were observed over a six week postnatal 
period for signs of gross developmental abnormalities. One 
mouse was found to be stunted (weight = 7 g at six weeks of 
age while control weighted 25 g). No other developmental 
abnormalities were noted. The route and week of maternal 
inoculation with MVM did not alter the overall weights and 
TABLE 8. 
51 
Isolation of minute virus of mice (MVM) from mouse 
fetuses following maternal inoculation* 
Period during Number of Number of 
gestation of Litter fetuses present fetuses with Percentage 
inoculation number and examined detectable MVM with MVM 
Third Week 1 10 8 80 
2 1 1 100 
3 6 lJ 66.6 
TOTAL 17 13 77 
Second Week 4 10 9 90 
5 12 11 92 
TOTAL 22 20 91 
Controls 6 9 0 0 
* Mice were inoculated during the third week (intrauterine) 
or second week (intraperitoneal) of gestation with 
105.0 TCID of MVM and sacrificed between 18-20 days of 50 
gestation. MVM was isolated by subinoculation of a 1:40 
(W/V) suspension of a whole fetus in rat embryo cells. 
TABLE 9. 
Week of 
maternal 
inoculation 
Third 
Sub-total 
52 
Isolation of minute virus of mice (MVM) from mice 
delivered following maternal mouse inoculation* 
Number with Percentage 
Ag.e of Number detectable with 
neonate tested MVM MVM 
Delivered 27 4 14 
1 week 16 3 18 
2 weeks 21 3 14 
3 weeks 24 7 30 
88 17 20 
-----------------------------------------------------------------
Second Delivered 9 3 33 
1 week 7 7 100 
2 weeks 11 2 19 
3 Weeks 4 2 50 
4 weeks 10 _]_ 70 
Sub-total 41 21 51 ------------------------------------------------------------------
First 
Sub-total 
Delivered 
1 week 
2 weeks 
3 weeks 
1 
0 
1 
2 
4 
1 
0 
0 
0 
1 
100 
0 
0 
25 
-------------------------------------------------------------------
GRAND TOTAL 133 39 30 
* Mice were inoculated during the third week (intrauterine) or 
second and first week (intraperitoneal) of gestation with 
105.0 TCID50 of MVM. MVM was isolated by subinoculation of a 
1:40 (W/V) suspension of neonatal tissues in rat embryo cells. 
Neoates has no evidence of clinical illness when selected 
from littermates. 
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growth rate of the neonates (Figure 6). These weights and 
rate of growth did not vary significantly from those of the 
control mice (p>0.05). 
A small number of first generation survivors were mated 
and the progeny were observed for abnormalities. Grossly, 
there were no demonstrable abnormalities and the number of 
surviving progeny did not statistically differ from the 
controls (Table 10). 
Teratogenic studies with Colorado tick fever virus 
Because Colorado tick fever (CTF) virus has never been 
investigated for possible teratogenic effect, pilot studies 
were initiated to determine if this virus might be a teratogen 
for mice. Re5ults of these studies indicated that CTF virus 
might be an unsuspected teratogen. Thus, more extensive 
studies with this virus were performed. 
In order to determine the teratogenic effects of CTF 
virus in mice, a total of 113 "timed pregnant" mice were 
purchased for experimental studies. Of these, 69 pregnant 
mice, divided into groups by gestational periods and route of 
inoculation, were inoculated with 106 -3 TCID
50 
CTF virus. 
The remaining 44 "pregnant" mice served as controls. Partur­
ition data for these inoculated mice are given in Table 11. 
As can be seen, less than one-half of these mice (40 of 84) 
actually delivered. However, since the percentage of deliv­
eries is essentially the same in virus inoculated and control 
mice, it is unlikely that the CTF virus did contribute 
substantially to the failure of the mice to deliver; b�t 
54a 
FIG. 6. Comparison of weight gains of surviving neonates 
delivered of mothers uninoculated and inoculated with 
minute virus of mice (MVM). Pregnant mice were inoculated 
with 10 5.0 TCID50 of MVM during the first (IP), second 
(IP), or third (IP and IU), week of gestation. Delivered 
mice were weighed individually and the average weights of 
mice for each gestational group are plotted. Th� results 
are expressed as mean weight/ mouse (gram). 
Legend. 0 0 Control 
6. 6 MVM first week gestation 
0 0 MVM second week gestation 
1!1-. ;(ii\ MVM third week gestation 
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TABLE 10. Effect of materna1·1noculation with minute virus 
of mice (MVM) upon the viability of second 
generation progeny 
MVM Control 
Number of litters 4 7 
Total livebirths 40 73 
Average livebirths per litter 10 10.5 
Stillborns 0 0 
Neonatal deaths (day 0-29) 1 1 
Percent neonatal death 2.5% 1.5% 
TABLE 11. Parturition data of mice inoculated with Colorado tick fever virus 
Inoculum Total mice Livebirths Stillbirths 
Week of Dose Average 
gestation TCID50 Route* Inoculated/Delivered Total litter Total % 
-
Third 106
.3 IU 15/11 (+3)** 112 10.0 8 6 
106.3 IP 14/12 120 11. 0 2 1.75 
Diluent:/- IU 5/3 (+l) 35 12 0 0 
Uninoculated - 8/8 96 12 0 0 
Second 106.3 IP 20/8 (+2) 43 5.4 32 45 
Diluent IP 5/3 26 9 0 0 
Uninoculated - 11/4 ( +l) 37 9 0 0 
First 106.3 IP 20/3 35 12 5 12. 5 
Diluent IP 5/0 0 - 0 
Uninoculated - 10/1 9 9 0 0 
* IU = Intrauterine, IP = Intraperitoneal. 
** Number of litters sacrificed between day 18-20 of pregnancy. 
-I EMEM with 10% FCS and antibiotics. 
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rather the commercial mice were not pregnant when obtained. 
Of a total of 357 mice born to CTF virus inoculated mothers, 
47 were stillborn. There were no stillborns in a combined 
total of 203 mice born to control mothers. The increased 
number of stillbirths in the litters of intrauterine (IU) 
inoculated mothers during the third week of gestation and in 
the litters of mothers inoculated intraperitoneally (IP) 
in either the first or second week of gestation was highly 
significant, when compared to controls which showed zero 
stillbirths (p<0.01). However, there was no statistical 
difference between the stillborn incidence in the litters 
born to mothers inoculated IP during the third week of gest­
ation when compared to controls (p>0.05). Among the mice 
inoculated IP ttith CTF viruG, mice inoculated durins the second 
week of gestation showed a significantly greater incidence of 
stillbirths over the other gestation weeks (p<0.01). 
In addition to parturition data, neonatal mortality and 
surviving mice were recorded (Table 12). There was no 
significant difference within the control groups (uninoculated 
and diluent inoculated); thus, these control groups were 
pooled for use in statistical analysis. In all four groups of 
mice inoculated with CTF virus, there was a statistically 
significant (p<0.01) increase in the total neonatal mortality 
for each group as compared to the controls. The incidence of 
neonatal mortality in the first and second week of gestation 
groups was increased significantly (p<0.05) over the third 
week of gestation group. Furthermore, the increased incidence 
TABLE 12. Incidence of neonatal mouse mortality following maternal inoculation with 
Colorado tick fever virus 
Number of 
neonatal mice 
Inoculum studiec. 
Week of Dose 
gestation TCID50 Route* -
Third 106.
3 
IU 88 
106.
3 
IP 99 
Diluentl'* IU 24 
Uninoculated - 80 
Second 106.
3 
IP 43 
Diluent IP 16 
Uninoculated - 34 
First 106
.3 
IP 24 
Diluent IP 0 
Uninoculated - 8 
* 
** IU = Intrauterine, IP = Intraperitoneal
. 
EMEM with 10% FCS and antibiotics. 
Neonatal deaths 
Days postpartum 
0-9 10-19 20-29 Total % 
23 5 3 31 35 
14 11 1 26 26 
1 0 0 1 4. 
5 0 0 5 6 
19 1 0 20 47 
1 2 0 3 18 
2 0 0 2 4 
7 4 1 12 50 
0 0 0 0 
0 1 0 1 12 
VT 
co 
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of neonatal deaths in the period 0-9 days, following 
delivery, was significantly greater than the inc�dence of 
neonatal deaths in the period 10-29 days (p<0.05). Within 
the four groups, there was no significant difference in 
the incidence of neonatal deaths in the IU and IP inoculated 
mothers during the third week of gestation nor between mice 
inoculated IP during the first and second week of gestation 
(p70.05). 
Because viral replication in the fetus is n-ot necessary 
for teratogenesis (1, 2, 4, 10), studies were undertaken 
to determine if the teratogenic effects seen with CTF virus 
were due to replication of virus in the fetus. Three mice 
were inoculated IU during the third week of gestation and 
two mice were inoculateJ IP during the second week of 
gestation. These five mice were sacrificed one to three 
days before delivery and thei� uteri were removed, opened 
and inspected for fetal abnormalities (Table 13). Only one 
fetus was found in one of the litters. One blighted 
(undeveloped) embryo was noted in each of two litters. 
Partial reabsorption was noted in one litter. Individual 
fetuses were triturated and the resultant suspensions were 
assayed for the presence of CTF virus. Of the fetuses 
obtained from mice inoculated during the third week of 
gestation, 76% had detectable CTF virus. Of those fetuses 
obtained from mice inoculated during the second week of 
gestation, 53% had detectable CTF virus. None of the 
control fetuses tested had detectable CTF virus (Table 13). 
TABLE 13. 
60 
Isolation of Colorado tick fever (CTF) virus 
from mouse fetuses following maternal inoc­
ulation * 
Number of 
Period during Number of fetuses with Percent-
gestation of Litter fetuses present detectable age 
inoculation number and examined c rrF' virus CTF 
Third Week 1 11 10 
2 1 1 
3 10 6 
TOTAL 22 17 
Second Week 4 5 3 
5 12 6 
TOTAL 17 9 
Controls 6 10 0 
* Mice were inoculated during the third week (intrau­
terine) or second week (intraperi toneal) of gest-­
ation with CTF (106 ·3 TCID
50
) and sacrificed 
between 18-20 days of gestation. CTF was isolated 
by subinoculation of a 1:40 (W/V) suspension of 
a whole fetus in L929 cells. 
with 
virus 
91 
100 
60 
76 
60 
50 
53 
0 
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Various tissues of the five sacrificed mothers were 
assayed for virus content (Table 14). CTF virus was not 
detectable in any of the plasma fractions, but was present 
in four of five erythrocyte fractions and organ suspensions. 
Virus titers in these tissues ranged from 103.0 to 105 ·
0 
TCID50/ml. Placental pools from all five mothers were 
positive for virus and had at least 200 fold.more virus 
than corresponding maternal tissues. Fetuses selected 
at random from the litters were also assayed for. CTF virus. 
Virus titers varied from 103.0 to 10 7.0 TCID /gm in these 
50 
fetuses. Of the 11 fetuses tested, nine had higher titers 
than their corresponding maternal organs. The two blighted 
embryos were titered for CTF virus content and were found 
to have titers of 10 6 -0 and 10 6 ·5 TCID
50
;g� (T�ble llt). 
In a continuation of CTF viral studies, where possible, 
specimens were collected from mice born dead or dying 
during the neonatal period. In addition, a selected number 
of liveborn mice were collected on the day of delivery and 
a selected number of normal appearing neonates were 
sacrificed at intervals. All specimens were screened for 
th� presence of CTF virus, usually at a 1:40 dilution but in 
some cases at 1:100 dilution. 
Of the mice born to mothers inoculated during the 
third week of gestation, 6 6% of the stillborns and 55% 
of the dying neonates had detectable CTF virus (Table 15). 
Only one of 29 liveborn neonates collected at delivery had 
detectable CTF virus. None of the 52 surviving neonates 
62 
TABLE 14. Titers of Colorado tick fever (CTF) virus in 
various maternal and fetal tissues 
Tissue source Third week pregnancy* Second week 
l** 2 3 4 
Maternal *** 
Plasma � 100.5 6 100.5 !!:: 10
0.5 � 100.
5 
Erythrocyte 103.0 103.
5 
103.0 103.
0 
Organs -/ 105.0 103.0 103.0 103.0 
Placenta 107-5 107-25 10
5.25 106.
0 
Fetuses 
Fetus a) 10
6.5 
103.0 10
5.25 
107.
0 
Fetus b) 106.
5 
104.
25 
106.
0 
· Fetus c) 106.
5 
ND -/-/ ND 
Fetus d) 104.
5 
ND ND 
pregnancy 
5 
!!:: 100.
5 
� 100.
5 
6 100.5 
103-
5 
103.0 
103.0 
ND 
ND 
* Pregnant mice were inoculated with 106-3 TCID50;0.1 ml 
of CTF intraperitoneal for second week of pregnancy and 
intrauterine for third week of pregnancy. 
** 
*** 
The litter number corresponds to that given in Table 13. 
Titers are expressed as TCID50/ml for erythrocyte and plasma 
�amples and as TCID50;gram for other tissues. 
Organs included pooled long bone, spleen, liver and kidneys. 
ND = Not done, - = no fetus available for examination. 
TABLE 15. Isolation of Colorado tick fever (CTF) virus from mice 
delivered following maternal inoculation* 
Number 
Category Number positive for Percentage 
Inoculum period examined tested CTF virus positive 
Third week of Liveborn 29 1 3.3% 
gestation deliveries 
Stillborns 11 7 66.6% 
Neonatal· 22 12 54.5% 
deaths 
Surviving 52 0 0 
mice 
Second week of Liveborn 6 5 83.3% 
gestation deliveries 
Stillborns 16 13 81.2% 
Neonatal 5 2 40.0% 
deaths 
Surviving 19 0 0 
mice 
Controls** Liveborn 4 0 0 
deliveries 
Stillborns 0 0 0 
Neonatal 1 0 0 
deaths 
Surviving 37 0 0 
mice 
* CTF virus was isolated by inoculation orito 1929 cells with 
sample suspensions at a 1:40 dilution or at a 1:100 dilu­
tion. 
** Uninoculated and diluent inoculated controls were pooled for 
this comparison. 
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had detectable virus, however, most of this latter group 
were collected three to four weeks postpartum. In contrast, 
the litters of mothers inoculated during the second week 
of gestation were more heavily infected. In this group 
80% of stillborns, 83 % of the liveborn neonates collected 
at delivery, and 40% of dead neonates had d�tectable CTF 
virus while none of the surviving mice had virus. None 
of the control litters demonstrated any evidence of CTF 
virus (Table 15). Thirty-seven of the specimens· with 
detectable virus were quantitated for virus content. Only 
three specimens had titers of greater than 104 ·0 TCID50;gm, 
whereas, 30 of the specimens had titers less than 103 .0 TCID50;gm. 
Serological studies were performed upon randomly selected 
neonates, three and four weeks of age, to determ:lne t11e pres-
ence or absence of antibody to CTF virus (Table 16). For 
these studies, a 1:10 dilution of supernatant fluid from 
ground tissues was used as the source of antibody. Control 
rnice did not have any detectable antibody. Two mice that 
delivered within one day of maternal inoculation did not 
have detectable antibody to CTF virus. Specimens of all 
other neonates inactivated CTF virus when tested by virus 
neutralization in cell cultures. One of these neonates, 
was delivered three days following maternal inoculation; 
whereas, all of the remaining neonates were delivered 
between 7 to 15 days following maternal inoculation. 
Another aspect of the potential teratogenic effect 
of viruses includes the developmental characteristics of 
the offspring. Each mouse delivered was weighed individually, 
TABLE i6. 
Week during 
gestation of 
inoculation 
Third 
Second 
Controls 
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Serological studies of neonatal mice following 
inoculation with Colorado tick fever (CTF) 
virus * 
Percent with 
Number Number detectable 
tested positive antibody to CTF 
4** 2 50 
11 11 100 
5 0 0 
* Tissue (bone, liver, spleen and kidney) specimens were 
obtained in the third and fourth week. The ten percent 
suspensions were prepared and supernatant fluid collected. 
Serological results were obtained by virus neutralization -
equal parts of the supernatant plus CTF 103 -5 TCrn
50
ml, 
mixed and incubated one hour at 37 C and inoculated onto 
L929 cells. A positive result was considered as 
complete neutralization of viral CPE. 
** Two neonatal mice which delivered within 24 hours follow­
ing maternal intrauterine inoculation with CTF virus 
had no detectable antibody to CTF virus. One mouse 
delivered at three days and another at seven days after 
maternal intrauterine inoculation had detectable antibody 
to CTF virus. 
at delivery, and the survivors were weighed weekly over the 
next six weeks. The compiled averages of these weights 
are illustrated in Figure 7. There was no significant differ­
ence in the average weight nor the rate of growth of any of 
the CTF virus inoculated groups from the controls (p�0.05). 
There were several observations made of the offspring of 
mothers inoculated with CTF virus that are suggestive that 
developmental aberrations occurred. A tabulation of all the 
developmental aberrations is shown in Table 17 .. There were 
two instances of blighted embryos, six placental sites of 
partial reabsorption were noted; one mouse exhibited an 
absent eye, and two mice were stunted (i.e. at four and six 
weeks each weighed seven grams). Also, 14 mice exhibited 
ncurologic�l disturbances such as paralysis, inability to 
turn over when placed upon their back, and sluggishness at 
two and three weeks of age. The overall incidence of develop­
mental aberrations was 6.4%. The only abnormality noted in the 
203 control mice was one mouse which was stunted (incidence = 
0.5%). 
One question often raised in discussing a teratogen is the 
potential effect upon second generation progeny (or succeeding 
generations). In a small analysis of this aspect, first 
generation mice that survived the neonatal period were mated 
and the progeny observed. There was no decrease in birth 
viability nor significant increase in neonatal mortality in 
the second generation progeny (Table 18). 
In order to prove that the teratogenic effects seen were 
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FIG. 7. Comparison of weight gains of surviving neonates 
delivered of mothers uninoculated and inoculated with 
Colorado tick fever (CTF) virus. Pr�gnant mice were inocu­
lated with 10 6 -3 TCID50 
of CTF virus during the first (IP), 
second (IP) or third (IP and IU) week of gestation. Deliv­
ered mice were weighed individually and the average weight 
of mice for each gestational group are plotted. The results 
are expressed as mean weight/ mouse (gram) . 
Legend. ..,_ ___ Q 
6----6 
@----� 
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TABLE 17. Developmental aberrations observed in first 
generation mice following maternal inoculations 
with Colorado tick fever (CTF) virus 
Total number of first generation CTF virus mice 398 
Blighted embryos 2 
Partial reabsorption 6 
Absent eye 1 
Stunting * 2 
Neurological ** 14 
Total anomalies 25 (6.4%) 
-------------------------------------------------------------
Total number of first generation control mice 
Stunting 
Total anomalies 
* Stunting = 7 g at six weeks age. 
203 
1 
1 (0.5%) 
·** Neurological = Paralysis, inability to turn over or 
stand, sluggish at 2-3 weeks. 
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TABLE 18. Effect of maternal inoculation with Colorado 
tick fever (CTF) virus upon the viability of 
second generation progeny 
CTF CONTROL 
Number of litters 14 7 
Total livebirths 153 73 
Average livebirths/litter 11 10.5 
Stillbirths 0 0 
Neonatal deaths (0-29 days) 9 1 
Percent neonatal death 6.6% 1.5% 
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due to CTF virus, a neutralization test was performed in 
pregnant mice. Either control serum or specific CTF virus 
antiserum (neutralization index of 104 ·5) was mixed in 
equal parts with 104 ·3 TCID50/ml of CTF virus. Following 
incubation of the virus serum mixture, mice in the second 
and third week of gestation were inoculated IP. The 
results are shown in Table 19. In mothers inoculated during 
the third week of gestation, there were no stillbirths. 
However, 50% of the neonates born to mothers inoculated with 
normal serum plus CTF virus died compared to 14% of the 
neonates born to mothers inoculated with CTF virus and 
antiserum. When maternal mice in the second week of ges­
tation were inoculated with normal serum and CTF virus, the 
resultant litters had seven percent stillbirths and 43% 
neonatal mortality. In contrast, the maternal mice, 
in the second week of gestation, inoculated with CTF virus 
and antiserum resulted in no stillbirths and only 10% 
neonatal mortality. For both gestational periods, statis­
tical analysis of the data confirms the effectiveness of 
specific antiserum to counteract the teratogenic effect 
of CTF virus to a probability of <0.01. 
Thus, from these experiments, CTF virus was demonstrated 
to cross the placenta, re�licate in the fetus, and to 
produce teratogenic effects. These effects were particularly 
noted as to fetal wastage and neonatal mortality. 
TABLE 19. Neutralization of the teratogenic effects of Colorado tick fever (CTF) virus 
by specific antiserum 
Inoculum* Total mice Livebirths Stillbirths Neonatal deaths 
Dose Average 
Agent TCIDso Inoculated/Delivered Total litter Total % Total % ** 
A. Third week of gestation 
CTF 104.3 
+ 2/2 16 8 0 0 8 50 
Normal serum 
CTF 104.3 
+ 6/6 61 10 0 0 9 14 
Antiserum 
Uninoculated - 8/8 96 12 0 0 5 5 
B. Second week of gestation 
CTF 104.3 
+ 5/4 43 11 3 7 18 43 
Normal serum 
CTF 10
11.3 
+ 12/6 70 12 0 0 7 10 
Antiserum 
.Uninoculated - 11/4 37 9 0 0 2 4 
* Route of inoculation was intraperitoneal. 
** The percent neonatal death is based upon the number of livebirths in the litter. 
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DISCUSSION 
One of the major difficulties in conducting studies 
with MVM is assaying the virus aqcurately in in vitro systems. 
Although hemagglutination (20), fluorescent antibody (21), 
and plaque assay (45) methods have been used for the assay 
of MVM, the most sensitive assay system was described by 
Parker (21), who demonstrated the virulence of minute virus 
of mice (MVM) for replicating REC. One of the difficulties 
with Parker's REC system is the time and expense involved 
in the preparation and culturing of primary and secondary 
REC. Therefore, in the present studies, preliminary exper­
iments were performed to determine if MVM could be easily 
and accurately assayed in readily available cell culture 
lines. Six different cell lines were compared to REC for their 
sensitivity to MVM. None of the cell lines was found to be 
as susceptible to the effects of MVM as was REC. Two of 
the cell lines, 1929 and WI 38 cells, did show evidence of 
CPE when inoculated with high concentrations of MVM (Table 3). 
The other cell lines used failed to show CPE with any dilution 
of virus inoculated. Therefore, the CPE method of Parker 
(21) using REC was considered to be the best system for 
assaying MVM despite the difficulties involved. 
The susceptibility of MVM to inactivation by laboratory 
chemical disinfectants has not been reported in detail. In 
the present experiments, all the chemicals tested inactivated 
the infectivity of MVM under the conditions used (Table 4). 
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In a previous study, Crawford (20) reported that 1.8% 
formaldehyde denatured the DNA of MVM causing a shift of the 
absorption maximum to a longer wave length. The present 
studies extend t�ese findings and show that as little as 
0.5% formaldehyde completely inactivates titratable virus. 
In our hands, chloroform also inactivated the virus, which 
is in contrast to the findings of Parker (21), who reported 
that treatment of MVM with chloroform had no effect on the 
induction of either cytoplasmic or nuclear fluorscence of 
infected cells. However, the concentration of chloroform used 
and the deta'ils of t:rea tment are not given in Parker's work. 
The fact that in the present study, chloroform did inactivate 
MVM is of interest, as chloroform is frequently used to 
distinguish between enveloped and non--enve loped vi 1·uses ( 4 6). 
The infectivity of enveloped viruses is destroyed by treat­
ment with chloroform due to disruption of the physical 
integrity of the virion. The disrupted virions probably fail 
to attach to susceptible cells. The Parvoviruses are non­
enveloped viruses and only a few other non-enveloped viruses 
have been reported whose infectivity is affected by lipid 
solvents. Fowlpox virus is very susceptible to inactivi­
ation with chloroform, but with other pox viruses such as 
vaccinia, the degree of inactivation is rarely greater 
than 99% (46, 47). In the present studies, due to the 
toxicity (at the lowest dilution used) of chloroform for 
REC, the inactivation of MVM by chloroform could not be 
determined precisely. However, at least 90% of MVM had 
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been inactivated, which indicates that MVM is a non-enveloped 
virus which is sensitive to inactivation with chloroform. 
There have been no previous studies performed on 
actual infectivity titers of MVM following acid treatment. 
In this study, MVM had a decreasing infectivity for REC 
over a period of time when held at pH 2.0 (Figure la and b). 
By percent survival, 98% of MVM was inactivated after one 
day of pH 2.0 treatment. However, it required 11 days to 
inactivate completely demonstrable MVM infectivity. 
Crawford (20) had shown that at pH values between 7.0 and 
8.5, the HA activity of MVM was not affected, and Greene 
(48) had demonstrated that the HA activity of Toolan's 
H�l virus, an6ther Pa�vovirus, �as stable to wide ranges of 
pH (2.0 to 11.0) and heat. Although Greene (48) pointed 
out that the hemagglutinin appears to be the virus 
particle, his studies do not negate the present findings, 
as infectivity does not necessarily reflect hemagglutinating 
ability. It appears that there is a small fra�tion of MVM 
which is acid stable over a short period of four to seven 
days. 
It is a commonplace observation that most animal 
viruses kept as suspensions in liquid, lose infectivity 
rapidly at room temperatures and more rapidly still if they 
are held at higher temperatures (49). The reasons for 
this instability are not precisely known. One of the 
reasons for inactivation may be enzymatic damage to th� 
viral coat, which may render the particles physically 
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unstable, or unable to attach to susceptible cells, or 
perhaps li�ble to rapid intracellular digestion instead of 
uncoating. Another reason postulated is that as the temper­
ature is elevated, heat denaturation of viral protein 
occurs. In contrast to the usual viral response to 
heat, it has been inferred that the Parvoviruses are 
relatively heat stable (22). However, our studies with 
MVM indicate that this virus is more heat sensitive than 
other Parvoviruses. More than 90% of MVM infectivity was 
inactivated at temperatures of 35 C, and above, within 
three hours. These results are in contrast to other studies 
on Parvoviruses by Poole (50) and Hoggan et al. (51). 
Hoggan and coworkers demonstrated that the half-life of 
adeno a�soci2t2d v�rus infectivity at 60 C was 30 minutes as 
compared to 15 minutes at 60 C for MVM in our studies. 
Similarly, Poole (50) reported that the titer of feline 
panleucopenia virus was unaltered following heating at 56 C 
for 60 minutes. Panleucopenia virus seems to be one of the 
most stable of the Parvoviruses as definite loss of 
viability at 37 C was noted only after 180 days (50). 
One of the possible explanations for the disagreement 
between these reports and the present studies is the effect 
of ionic balance in the suspending medium. For example, 
high molar concentrations of magnesium salts have profound 
and different effects on the thermostability of different 
viruses. The infectivity of a reovirus suspensicn is 
actually enhanced by heating at 50 C in the presence of 
MgC12 (52). Herpes simplex virus can be stabilized by 
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Na2so 4 but is extremely thermosensitive in the presence of 
isotonic salt (53). It was concluded from further exper­
iments that protection by protein solutions was probably 
effected, in part, by counteracting the thermonsensitizing 
effects of salts rather than by a direct effect on the. 
virions. In the present study, the pH .of the suspending 
medium was ca. 7.2, but no special attention was given to 
salt concentrations or alterations in sensitivity due to 
different ionic concentrations. The previous reported 
studies with Parvoviruses do not mention the salt concen­
tration of the suspending media. It was also interesting to 
note in the present studies that at 35 C, 45 C, and 60 C, 
there was a tapering of the percent survival of MVM 
lr1fectlvlty, such that the inactivation curves were not 
linear. At these temperatures, there appeared to be a 
surviving fraction of heat resistant MVM infectivity. 
In general, animal viruses remain viable for days at 
O C and almost indefinitely if frozen and stored at -70 
or below. MVM conformed to this general pattern and was 
relatively stable at refrigerator temperatures (4 C). 
When refrigerated over a ten week period, there was a loss 
of viral infectivity titer of 4.3 log10. However, here 
again other Parvoviruses are more stable. For example, 
Poole (50) demonstrated the feline panleucopenia virus 
did not lose viability when stored over 13 months at 4 C 
in a liquid or a lyophilized state. From the data obtained 
with MVM, it appears that MVM is relatively stable at 4 C, 
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but not as stable as has been reported with other Parvo­
viruses. Furthermore, there was no loss of MVM infectivity 
after nine months of storage in liquid nitrogen (ca. -196 C). 
Proctor et al. (54) studied the inactivation of Kilham's 
rat virus (KRV) with ultraviolet (UV) radiation, and found 
that for doses inactivating 98% of KRV infectivity, the 
survival curve was linear. Using a "weighted sensitivity" 
formula, Proctor et al. found that the dose for 37% sur­
vival (n
37
) of infectious KRV was 130 ergs/mm. 
In the present study, MVM was subjected to UV radiation 
at 20 ergs/mm2/sec. After five seconds (the shortest time 
period used), 98% of the virus was inactivated. However, 
an increased dosage up to 500 ergs/mm2 was necessary to 
inactivate effectively the detectable residual virus. 
Based upon the data obtained, the maximal n
37 
of infectious 
MVM was 65 ergs/rnm2 in comparison to the reported value of 
130 ergs/rnm
2 for KRV (54). Thus, a lower UV dosage inactiv­
ated a higher percentage of MVM infectivity than was seen with 
KRV. One possible explanation for the differences seen 
may be the effect of different suspending media. However, 
another interesting comparison can be made with phage 
0X 174. Crawford et al. (55) demonstrated that the DNA of 
MVM appears to be similar in size and structure to 0X 174 DNA.. 
Studies with 0X 174, as to sensitivity to UV radiation, 
have shown the viral n37 to be ca. 63 ergs/rnm
2 (56,57). 
From the data in the present studies with MVM, it appears 
that MVM is comparable to 0Xl74 in UV sensitivity. In 
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comparing "wej_ghted sensitivities" of KRV and 0Xl74, 
Proctor et al. (54) showed that 0X 174 was twice as 
sensitive to UV radiation as was KRV. Thus, our data are 
compatible with the available information. comparing 0X 174 
to KRV. 
A low percentage of MVM was resistant to UV inactivation 
A similar phenomena was noted with heat and acid inactivation 
studies. The reasons for this characteristic "resistant 
population" of MVM are as yet unclear. One explanation may 
be a temperature resistant mutant viral population, such as 
reported with poliovirus (58). In the present study, this 
possibility cannot be ruled out. In the only other reported 
study with Parvoviruses, Bachmann (59) failed to find 
temperature sensitive mutants. Another explanation for this 
resistant population is that MVM may form aggregates of 
virus particles or virus and cellular components which 
prevent destruction of all the virus by the environmental 
stimulus. This phenomena has been demonstrated to occur with 
poliovirus and other viruses (60), In gradient density 
studies, Crawford (20) noted aggregates of MVM which caused 
him some difficulty in the initial characterization of the 
virus. Perhaps viral aggregation is the best explanation 
for the MVM "resistant population" seen in the present 
studies. 
In summarizing the stability studies, it is evident 
that MVM can be inactivated by UV radiation, by temperatures 
of 45 C, 60 C, and 100 C, and the usual disinfectants, 
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such as sodium hypochlorite, formaldehyde, chloroform,· 
isopropanol, and ethanol. As there have been no reports on 
methods to handle MVM contamination, the data reported 
here should prove highly useful. Such chemicals could be used 
routinely to disinfect laboratory areas after accidental 
contamination or for washing animal ca�es for decontamination 
purposes. In addition, studies with UV inactivation and 
certain chemicals, such as formaldehyde, may prove useful 
in developing an inactivated vaccine for MVM. �uch a 
vaccine could be beneficial in preventing MVM infection of 
mouse colonies, particularly in laboratories working with 
murine tumor systems, which are frequently contaminated 
with MVM (22, 61). 
In preliminary studies of the teratogenic effects of 
MVM, an attempt was made to answer one of the major questions 
in the area of maternal-fetal virology and teratogenesis: 
why do only certain viruses cross the placenta to produce 
teratogenic effects? Mims (24) stated that viruses circul­
ating free in the plasma are rapidly cleared from the blood 
stream, but whenever viruses are associated with red 
blood cells, the viremia persists for longer periods of 
time. Furthermore, the form in which a virus arrives at 
placental villi, may markedly affect placental infection. 
A high level of viremia with virus unbound in the plasma 
may be requisite for passage of the virus through the 
placental barrier, while a relatively low viremia of 
erythrocyte associated virus persisting over a number of 
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days may suffice (24). 
Two of the teratogenic Parvoviruses (KRV and Toolan's 
H-1 virus) have been shown to be associated with the 
erythrocyte in vivo (16, 17). The association was firm 
enough to withstand three washings with tissue culture 
fluid. Portella (62) studied the attachment of KRV to 
erythrocytes by electron microscopy and he suggested that 
nucleated erythrocytes in peripheral blood in newborn 
animals might serve as a circulating carrier for virus. 
Such erythrocytes resulted from residual fetal hematopoiesis. 
The association of virus and erythrocytes could be 
either physical adsorption of the virus to the erythrocyte 
surface, or infection of the erythrocyte precusor cell and 
subsequent production of virus during erythrocyte maturation. 
Several viruses (Colorado tick fever virus, Friend leu­
kemia virus (FLV), Rauscher leukemia virus, mammary 
tumor virus, and various viruses of lower vertebrates) 
have been found to be localized intracellularly rather than 
to be adsorbed on the surfaces of erythrocytes (35, 63, 64, 
65). The association of both CTF and FLV with erythrocytes 
apparently results from infection of erythrocyte precusor 
cells (35, 65). Furthermore, electron microscopy has 
demonstrated proliferation of FLV and KRV in "inert" 
mammalian erythrocytes, maintained in vitro, by showing 
budding of viral particles from the erythrocytes (62, 65). 
Previous studies by other workers with MVM revealed 
a peak titer of viremia within seven days (18, 23). In 
these earlier studies, whole blood had a lower titer of MVM 
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infectivity than most of the organs tested. With this back­
ground information, studies were performed with MVM in our 
laboratory to ascertain if the virus was associated with 
the erythrocyte fraction of the blood or free in the plasma 
fraction. For comparative purposes, adult male and female 
pregnant and nonpregnant mice were studied. With all three 
groups of animals, MVM was found to be firmly associated 
with the erythrocyte fraction of the blood-. Thus, the 
studies performed are consistent with data for ·other 
Parvoviruses. In addition, the peak viremia was between 
four to seven days after intraperitoneai inoculation 
confirming the studies of other workers (18, 23). 
Prior to performing teratogenic experiments with MVM, 
one factor considered was the possibility of differences 
in the severity of MVM infection between nonpregnant and 
pregnant female mice. This is of some importance as it is 
well known that in humans, pregnancy affects the patho­
genesis and the severity of several viral diseases. Small­
pox, hepatitis, influenza, and poliomyelitis are all more 
severe in pregnant women (66). From our data, with clinical 
observations and titers of infectlvity, there was no signif­
icant difference in the viremia level or duration between 
pregnant and nonpregnant females. In contrast, there was 
a significantly higher titer of MVM infectivity in males as 
compared to female pregnant and nonpregnant mice. Although 
not directly correlated with infectivity titers, differential 
sex susceptibility of animals has been demonstrated with 
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other viruses. For example, male mice have been noted to 
have an increased susceptibility to encephalomyocarditis 
(EMC) virus when compared to femaie mice (67). The explan­
ations for differential sex susceptibilities has not been 
adequately explained. 
If there were a difference in int�rferon (IF) production, 
this might be a possibility for dj_fferential sex suscepti­
bility. There have been·no previous studi�� as to IF induction 
by MVM. Because IF can be produced in vivo, it·1s reasonable 
to assume that the capacity of a virus to produce IF poorly 
or resist IF action would be an advantage to the invading 
virus. Our results showed that MVM induced very low levels 
of IF (Table 5). It might be suggested that the assay 
system, using L929 cells, was insensitive to IF, as it is 
known that the IF titer may vary with the test virus and 
cell system (68). However, the 1929 cells were sensitive 
to the GD-7 virus and standard mouse IF. This limited 
production of IF by MVM is consistent with the knowledge 
that DNA viruses are relatively inactive inducers of 
IF (69). In general, large molecular sizes of nucleic 
acid appear to be better IF inducers than smaller ones (69). 
As MVM is one of the smallest single-stranded DNA viruses 
(1.7 X 10 6 daltons), MVM would not have been expected to 
be a potent IF inducer. Most factors determining whether 
or not a virus induces IF in a given cell system remain 
unknown at the present time (68). However, one prerequisite 
for an inducing virus (of IF), is that the virus must 
not shut off cellular RNA (and protein) synthesis to a 
degree which would interfere with the synthesis of the IF 
molecule. For example, polioviruses cause an early inhibition 
of cell biosynthesis and, in general, polio infected cells 
produce little or no IF (70). By contrast, the Myxoviruses 
and Arboviruses which do not shut down cell biosynthesis 
are potent IF inducers (71). Of particular interest is the 
time sequence of appearance of IF after inoculation of the 
animal with the virus. For example, Newcastle disease, 
Sindbis, Sendai, or vaccinia viruses inoculated into mice 
result in the appearance of IF in the sera between one and 
four hours (?2). Using ectromelia virus inoculated via the 
footpads, the maximal titer for IF was noted six days after 
inoculation (73). The results of our studies show that MVM 
is a poor inducer of IF. Fur-thei'rnvre, the peak l;l te1· of 
IF is between seven to nine days after intraperitoneal 
inoculation. Therefore, it is suggested that IF does not 
play a significant role in the differences seen in the MVM 
titers of the erythrocyte fraction of the blood between 
male and female mice. 
In other experiments, the sensitlvity of MVM to the 
action of IF was studied. The results indicate that MVM 
is very sensitive to the action of IF, when compared to the 
reference virus, VSV. However, it must be remembered that 
the IF assay used with MVM was the yield reduction method 
which is more sensitive than the CPE assay method used 
with VSV (43). 
There is no prlma facie close correlation between the 
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ability of viruses to induce IF synthesis and their sensit­
ivity to the action of IF (69). The reference VSV is an 
example where the virus is a poor inducer of IF, but yet 
is very sensitive to IF (44, 74). The present study with 
MVM correlates well with previous studies that Kilham et al. 
(75) performed with another Parvovirus, KRV. These 
workers presented data demonstrating that rat virus was as 
sensitive as the reference virus, VSV, to the antiviral 
action of IF in rat cells. Furthermore, in vivo, rat virus 
was a poor inducer of IF, but the responses varied with 
different st'rains of rat virus. The titers of IF ranged 
from less than five units to a peak of 70 units in one 
sample. Thus, two members (KRV and MVM) of the Parvovirus 
group have been shown to have similar characteristics, 
in relationship to IF induction and sensitiiity to IF. 
Viral infection during pregnancy is well recognized 
as a significant cause of fetal loss and morbidity with 
congenital anomalies, retardation of fetal growth, and 
leukemia, �hich has been ascribed to a wide variety of 
viruses (76). Furthermore, a significant proportion of 
perinatal loss and morbidity is associated with inapparent 
viral infections in the mother, e.g. cytomegalovirus (11). 
The Parvoviruses have been shown to be very teratogenic 
and with little evidence of maternal infection in the natural 
host animal (19). 
The ability of the Parvoviruses to attach to erythrocytes, 
to pass directly across blood vessels, to attack both neural 
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and extraneural sites of high mitotic activity, to replicate 
in vascular endothelium, and to be transported in circul­
ating macrophages are features which account for their 
capacity to pass-maternal and placental barriers and establish 
fetal infection (16, 17). Of the Parvoviruses, MVM has 
been one of the least studied, but one with inapparent 
maternal infection and surviving infected fetuses (23). 
The present studies on MVM were performed to increase the 
knowledge concerning this most interesting teratogen. 
The results of the present studies indicate that fetuses 
infected in utero by placental transfer of virus are not 
severly damaged at birth, as there was no evidence of 
fetal reaborption, stillbirths, or con�enital anomalies. 
In contrast, fctuaos infected by in utero by direct inocul-
ation had a significant (p<0.01) increase in stillbirths. 
In the only other report of in utero MVM infection in mice, 
there was no evidence of stillbirths; however, the sample 
size (four mice from two litters) studied was small (23). 
It is known that MVM can produce stillbirths and fetal 
reabsorption in rats and hamsters (23). In studies of 
other Parvoviruses in various animal species, fetal 
reabsorption and stillbirths have been reported (16, 77). 
Previous studies with MVM in mice have not analyzed 
the effect of the virus upon the neonate. In our studies, 
intrauterine inoculation with MVM did not result in a sign­
ificant increase in neonatal deaths. Conversely, intra­
peritoneal inoculation with MVM during the first, second, 
or third week of gestation resulted in a significant increase 
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in neonatal deaths (within 30 days after birth) over the 
controls (p<0.05 for the third week and p<0.01 for the 
first and second weeks).· It is of note that the mice inoc­
ulated during th� earlier stages of gestation had the 
great.est incidence of neonatal deaths . . Unfortunately, the 
neonatal deaths could not be confirmed to be due to viral 
effect, as none of these specimens were suitable for viral 
isolation studies. Viral isolation studies were performed 
on randomly selected (over a four week period) ·surviving 
neonates and on fetuses from sacrificed mothers between 
day 18 and 20 of gestation. These surviving neonates had 
no clinical evidence of MVM infection or of. obvious struct­
ural residue as seen with other Parvoviruses (78). Similarly, 
there were no evidences of blighted embryos or fetal 
reabsorption, which agreed with the studies of Kilham and 
Margolis (23). In viral assays of fetuses and neonates, 
virus was isolated from 91% of the fetuses infected during 
the second week of gestation, and from 51% of the surviving 
neonates of this group. The results of studies of the fetuses 
and neonates infected during the third week of gestation 
were less impressive as only 77% of the fetuses and 19% 
of the neonates had detectable virus. As Parvcviruses have 
been shown to have an affinity for replicating cells, these 
data can be interpreted in this relationship. The cellular 
replication of the fetus is much greater during the second 
week of gestation than during the third week. Therefore, the 
increased percentage of infected fetuses and neonates from 
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those mothers inoculated during the second week of gestation 
is possibly due to the increased affinity of MVM for these 
replicating cells. 
Also requiring explanation is the finding that, 
although a high percentage of the fetuses were infected 
(i.e. detectable MVM on viral assay) one to three days 
before birth, at delivery only 14% of the third week and 
33% of the second week inoculated group� had detectable 
virus. There arc at least two possible explanations. 
The first explanation is that the delivered neonates 
had nursed and if maternal antibodies were present in the 
milk, the antibody obtained by the neonate could have 
interfered with the viral assay. This would be substantiated 
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mouse colonies are protected from early infection with MVM 
by maternal antibody which persisted in the neonate in low 
titers as long as six to eight weeks after birth. One of 
the problems with the antibody explanation is that the peak 
viremia for MVM is between four and seven days after 
inoculation, as shown in the erythrocyte study. Thus, a 
maternal antibody response may not be significant prior to 
the delivery, which usually occurred from 7 to 15 days after 
inoculation. 
The second explanation is that the fetuses were 
triturated in toto, whereas non neural organ samples were 
obtained from the neonates. As Parvoviruses have a known 
affinity for neural tissues (18), the failure to test 
brains from neonates could explain the low percentage of 
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neonates with detectable virus. 
Another feature of this study was that at four weeks of 
age, none of the 10 mice whose littermates had detectable 
MVM, were found to have detectable antibody to MVM. 
Because the mice used for serological studies were not 
assayed for virus (although seven of ten littermates 
collected at the same time had detectable virus}, it is 
possible that these mice were carriers of MVM and have 
perhaps been rendered immunologically tolerant by in utero 
MVM infection. That is to say that the embryonically 
infected mice might not recognize the virus as "foreign", 
and therefore, not make antibody or antibody could be bound 
to circulating virus. This bound antibody would perhaps not 
De detectable. 
The duration of infection and excretion of MVM, following 
congenital infection is not known (22). From our data, it 
can be said that evidence of MVM presence can be detected 
for at least four weeks following delivery (or four to six 
weeks after maternal inoculation). Cross contamination 
within the litter or reinfection could not be ruled out in 
this study under the conditions used. Our studies confirm 
previous data indicating that MVM does cross the placenta 
and cause infection compatable with fetal survival in mice. 
Previous studies have not been reported concerning the 
developmental characteristics of mice delivered of mothers 
infected during pregnancy with MVM. In our studies, the 
surviving neonatal mice were also observed for evidence of 
8§ 
developmental aberrations, at delivery and over a six week 
period. No abnormalities were detected. The weights and 
rate of growth in the surviving neonates did not vary 
significantly from those of the control mice. Other viruses 
have been observed to retard intrauterine fetal growth 
with resultant low birth weight (in humans and animals) and 
a decreased neonatal growth (78, 79). A previous study on 
neonatal MVM inoculation (intracranially and intraperiton­
eally combined) of mice, reported a failure of the inoculated 
mice to grow over the next three to four days. Two mice, 
which were followed for three and a half weeks, had not 
reached the weight of one uninoculated littermate (18). 
However, from the data reported in the present study, it 
appears that if the neonatal mice survive the MVM infection, 
there is no gross impairment of fetal development nor in the 
rate of growth. 
In the work with other Parvoviruses, cerebellar hypoplasia 
has been noted particularly with resultant clinical manifest­
ations (17, 78). Although, MVM does appear to be a more 
successful parasite than other Parvoviruses (23), the 
increased neonatal mortality, observed in this study, may be 
the first step toward the demonstration that in susceptible 
animals, MVM may be more closely related to the other Parvo­
viruses in causing fetal wastage. 
In the study on possible second generation effects of 
MVM, there were no effects seen and there were no increased 
neonatal deaths. There are no other reported studies of 
this type with Parvoviruses. It would appear that if .the 
90 
mouse survives the MVM infection, there is no increased 
risk to future progeny. 
An animal model for the rubella virus system is sorely 
needed (78, 80). Rubella and MVM have similarities in 
that both viruses cross the placenta, do not produce severe 
maternal disease, the effect on the fetus is inversely 
correlated with the age of the fetus, both have an affinity 
for replicating cells, both viruses are present in the 
newborn for prolonged periods, and both are excreted via the 
urine. MVM differs from rubella in that little evidence of 
fetal malformations, birth retardation, or developmental 
abberrations occur with MVM in mice. 'I;he ov.erall results 
with the MVM teratogenic studies suggest that this type of 
hos t-v:i.rus system mJ.ght ser've o.S a model fc,r th€= eub211a 
virus system. 
Colorado �ick fever (CTF) virus had never been invest­
igated for possible teratog�nic effects. Thus, when 
preliminary pilot studies indicated that CTF virus was a 
possible teratogen, more extensive studies were performed. 
Sever and London (10) have outlined guidelines for the 
consideration of experimental tera.togenesis. These guide­
lines were followed and the results of this study refer to 
these premises in proving that CTF virus is a teratogen for 
mice. 
The results of studies designed to demonstrate the 
teratogenic effects of CTF virus are based upon 398 mice 
resulting from 39 mothers inoculated with the virus during 
91 
gestation. Of the 39 mothers, 34 were allowed to deliver. 
Of the 357 mice born to the delivered mothers, 47 were 
stillborn. The incidence of stillbirths was particularly 
noteworthy in the group inoculated during the second week 
of gestation. In this group, 45% of the delivered mice were 
stillborn, reducing the average number of livebirths to 
5.4 as compared to the control of 11.0 mice per litter. It 
is well known that neonatal mice are very susceptible to 
CTF virus infection (32). From these studies, it appears 
that the fetus is likewise very susceptible to CTF virus. 
Not only were stillbirths noted, but six placental sites 
suggestive of partial reabsorption and the two blighted 
embryos (undeveloped) were also noted as additional examples 
of this susceptibility. Phese results are comparable to a 
recent and extensive report on the teratogenesis of another 
arbovirus in mice, Venezuelan equine encephalomelitis 
(VEE) virus (81). When VEE was inoculated during the second 
week of gestation, the average viable litter size was reduced 
from 9.9 (control) to 5.8 per litter. As was seen in this 
study, the diminished mean litter size was due to death and 
reabsorption of some fetuses being carried by each mother, 
rather than being due to death of all fetuses being carried 
by a few mothers. Also, bluetorigue virus, a Diplornavirus 
structurally similar to CTF virus, has been demonstrated to 
cause fetal death and reabsorption in mice inoculated 
during the second week of gestation (31). 
In our studies of the surviving neonates, the neonatal 
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mortality was markedly increased when compared to the pooled 
controls. Neonatal loss was very striking in the groups 
infected during the first and second week of gestation. 
Similar results were reported with VEE virus (81). 
The results of parturition data clearly indicate that 
CTF virus infection has a deleterious effect upon the 
outcome of the pregnancy. It appears that those fetuses 
exposed during the first and second weeks of gestation have 
a much greater chance of being stillborn; and, if born 
alive, survivors have almost twice the likelihood of 
neonatal demise than those exposed during the third week of 
gestation. The fact that mice congenitally exposed during 
the third week of gestation were less adversely affected 
may be explained because parturition occurred to0 soo11 after 
maternal inoculation to allow CTF virus to produce detrimental 
effects in the fetus. In addition, by the third week of 
gestation� fetal organogenesis may have developed to the 
point that the embryo is less susceptible to the effect of 
the virus. 
Although the occurrence of the stillbirth was great 
following maternal inoculation during first or second gesta­
tional week, there was a statistically higher percentage of 
stillbirths in the second gestational week (32/75;45%) as 
compared to the first gestational week (5/40;12.5%). It 
is interesting to note that similar results have b�en reported 
with VEE (81). Possibly, the results seen with CTF virus 
and VEE virus are related to the relative susceptibility of 
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of embryonic tissues at different periods of organogenesis. 
In an effort to determine viral presence, viral isolation 
studies were performed upon specimens of maternal tissues, 
placentas, fetuses, stillborns, and neonates collected from 
animals exposed to CTF virus during the second or third week 
of gestation� Specimens were not available for viral 
assay studies from animals exposed during the first week of 
gestation. Randomly selected "normal" delivered neonates, 
and neonates surviving and dying, over a four week period 
were included in these isolation studies. 
In assaying the fetuses and maternal tissues of sacri­
ficed mothers, several interesting features were noted. The 
fetuses from mothers inoculated IU during the third week of 
gestation showec� ths highest percentage /'76"') \ I 10 
with detectable CTF virus. In general, placental pools 
had the highest viral titer, indicating that the placenta 
is a highly favorable site of CTF virus replication. These 
results are of some interest as they are in contrast to 
results with MVM and Coxsackie B virus. With t;he latter 
viruses, the highest titers of infectivity have been found 
in the fetuses and not in the placenta or maternal organs 
(23). In our study, both the placentas and fetuses had 
higher titers of CTF virus than either maternal blood or 
organs. 
Viral isolation studies on stillborns collected at 
delivery generally confirmed that CTF virus presence was 
correlated with illness. The majority of stillborns and 
approximately one-half of neonatal deaths had detectable 
CTF virus. These data conform to the study with reovirus, 
in which high titers of infectivity were found in those 
neonates which died following maternal in utero infection 
(27). In our study, some CTF virus liveborn "normal" 
neonates collected on the day of delivery also showed virus 
presence; however, none of the mice which survived for one 
week or longer had detectable virus. It should be pointed 
out that the majority of the surviving neonates-were collected 
for virus isolation studies at three and four weeks of age. 
The failure to detect CTF virus in three to four week old 
neonates are in contrast to the study with reovirus. In 
the reovirus study, it was shown that apparently "well" mice 
ha.d very l1Jgh tlters of virus up to sev011 weeks aft�1· 
delivery (27). 
In general, the results with CTF virus differ from 
Spertzel et al. (81) with VEE virus, where there was no detec­
table virus in "normal" liveborn deliveries. In our study, 
the highest percentage (83.3%) of animals with detectable 
CTF virus occurred in "normal" liveborn deliveries of mothers 
exposed to CTF virus during the second week of gestation. The 
subsequent neonatal mortality in littermates of these mice 
was also the greatest (47%). Interestingly, only 3.3% 
of "normal" liveborn deliveries o.f mothers inoculated during 
the third week of gestation showed detectable virus. The 
reason for this low percentage, when 30% of littermates of 
these mice died as neonates, is unclear. Spertzel et al. (81) 
95 
suggested that fetal and neonatal wastage in the absence of 
detectable virus occurred due to some prenatal weakening 
or developmental defects. However, this explanation does not 
seem to hold true in our studies with CTF virus, as virus 
was readily isolated from "normal" liveborn delivered mice 
born to mothers inoculated during the second week of gestation. 
Similarly, CTF virus could be isolated from mice dying during 
the neonatal period. 
From the available data, it seems clear that. CTF virus 
will cross the placenta and replicate in the fetus resulting 
in an increased fetal and neonatal wastage. In general, the 
presence of CTF virus in the fetus or neonate indicated a 
likelihood of subsequent death. The mechanism by which 
dc�th occurs is a3 yet unclear. Because patholcgical studies 
were not performed, a direct structural defect cannot be 
discounted. Pathological studies with reovirus revealed 
pneumonic lesions, renal tubular necrois, and hydronephrosis 
resulting in the clinical findings of pulmonary and renal 
failure (27). Bluetongue virus has been shown to cause 
severe cerebral malformation in fetal mice (31). As some of 
the surviving mice in our study had neurological sequela, 
this possibility exists. Furthermore, cardiac destruction 
has been noted following CTF virus infection in young mice 
(82). Thus a possible cardiac anomaly may account for the 
increased stillb:lrth and neonatal death incidence. 
In order to determine if mice exposed congenitally to 
CTF virus developed immunity, a limited number of mice, which 
survived three to four weeks postnatally, were tested for 
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evidence of neutralizing antibody. None of these mice tested 
had detectable virus in their organs. Serological data 
revealed that two mice, which delivered within one day of 
maternal inoculation, did not have detectable antibody to 
CTF virus four weeks later. All of the remaining mice; 
which had antibody, had been delivered between 3 and 15 days 
after maternal inoculation with CTF virus. The detectable 
antibody may have been maternal in origin,.because of the 
time sequence between maternal inoculation and delivery. 
Hashmi et al. (27) did similar studies on reovirus and they 
concluded that maternal antibody was detectable in the 
neonate for as long as seven weeks. 
The effect of CTF virus upon the developmental charac­
teristics of the progeny was of particular interest because 
reovirus, a related Diplornavirus, has been shown to produce 
retarded growth and other obvious changes in congenitally 
infected mice (27). Several neurological aberrations were 
noted in the CTF virus neonates. Fourteen mice exhibited 
paralysis or sluggishness at two to three weeks of age. An 
additional mouse had an absent eye. This was the only eye 
defect noted in 398 mice, and is considered an observation 
worthy of careful followup in future studies. Thus, congenital 
infection with CTF virus does seem to result in develop-
mental abnormalities. In our study however, there was no 
difference in the average weight nor the rate of growth of 
mice exposed to CTF virus as compared to non-exposed controls. 
Sever and London (10) established guidelines to classify 
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an agent as a teratogen. First, the virus should be of low 
passage, well adapted to the animal, and preferably passaged 
in the living animal. This is because increased passages have 
been reported to increase or decrease the teratogenic effect 
of various viruses (10). The CTF virus used in the present 
study was well adapted to mice and had been passaged in the 
living animal. However, the virus had been passaged 88 
times in laboratory animals. Second, viral infection should 
be produced in the adult and fetus or newborn animals. 
Because CTF virus was found in maternal blood and organs, 
placentas, fetuses, and stillborns, and dead neonates, this 
criterion was fulfilled. Third, several intervals during 
gestation should be studied with different dosages and 
routea. In our studies, teratogenic effects were seen with 
three different gestational periods, two routes of inocul­
ation, and two different viral doses (104 -3 and 10
6
•3 TCio
50 
of CTF virus). Fourth, indirect effects on the mother or 
infant, environmental factors, mating patterns, and genetic 
background variables should be considered. In this study, 
control mice were subjected to the same environmental factors, 
including inoculation with diluent, feeding and general care, 
as were the virus inoculated groups. All mice were of the 
same genetic background and from the same commercial source. 
In addition, mice were randomly selected for virus inoculation 
or for controls. The fifth guideline is probably one of the 
most critical. This states that the teratogenic effects 
should be prevented by specific neutralization of the virus. 
In the present study, CTF virus specific antiserum was 
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obtained from the Research Reference Branch, NIH. The 
purity of this antibody is most important in determining 
that the teratogenic effects seen are not due to contaminating 
infectious agents or to materials in the inoculum. The 
antiserum used is know� to be highly specific, free of 
detectable adventitious agents, and free of antibody to a 
wide spectrum of murine viruses as well as other animal 
viruses. The neutralizction study revealed that the terat­
ogenic effects of CTF virus could be inhibited significantly 
by the specific CTF virus antiserum. 
In conclusion, based upon the findings reported here, 
we can add CTF.virus to the expanding known group of viral 
teratogens. 
lt was not the aim of this resea:ech to 1.;omr;aI'e the 
teratogenic effects of MVM and CTF virus. However, one is 
struck by several differences. Although both MVM and CTF 
virus are transported with the erythrocyte fraction of the 
blood, their teratogenic effects are very different in mice. 
MVM caused significant fetal wastage and neonatal mortality, 
but not to the extent seen with CTF virus. Both viruses were 
detectable in fetuses and neonates under one week of age. 
CTF virus was not detectable in neonates surviving three weeks 
or longer. However, detectable antibody (possibly maternal 
in origin) was observed in these surviving neonates. MVM 
persisted for prolonged postnatal periods of time without 
detectable antibody to MVM. Thus, congenital MVM infection 
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seemed to be more compatible with fetal and neonatal survival, 
whereas, congenital CTF virus infection seemed to have a 
much more lethal effect upon the fetus and resulting neonate� 
The different responses seen with these two teratogens 
demonstrate the importance of further studies in the areas of 
viral teratogenesis. Human congenital anomalies account for 
14% of infant deaths, but 60% of these have an unknown 
etiology. At the present, only 10% of these defects have 
been attributed to a viral etiology. Therefore� studies 
such as reported here are important for developing model 
systems by which the role and mechanism of action of viral 
teratogens can be determined. 
1db 
SUMMARY 
Studies were conducted in DUB/ICR mice with minute 
virus of mice (MVM), a single stranded DNA virus, and Colorado 
tick fever (CTF) virus, a double stranded RNA virus, to 
deter�ine if CTF virus had teratogenic potential and to 
characterize further MVM and its teratogenic effects. MVM 
is a known teratogen, whereas CTF virus had never been 
investigated previously for teratogenic potential. 
In characterization studies of MVM infectivity, the 
following were determined: (a) Rat embryo cells proved to 
be superior to six cell lines in assaying for MVM infectivity; 
(b) MVM infectivity could be inactivated with common labor­
atory disinfectants, ultraviolet radiation, temperatures 
45 C to 100 C, and acid treatment: although in some cases a 
resistant population of MVM was detected; (c) MVM was 
relatively stable at 4 C and was very stable when stored 
in liquid nitrogen; (d) In the infected mouse, MVM was found 
to be firmly associat�d with the erythrocyte fraction of the 
blood; (e) MVM was a poor inducer of interferon, but was 
sensitive to the action of interferon. 
In teratogenic studies with MVM infection in mice, 
incidences or 5% stillbirths and 12 to 25% neonatal deaths 
were noted. In addition, between 77% to 91% of fetuses, 
and up to 51% of surviving neonates (to four weeks of age) 
had detectable MVM. Growth rates, weight gains, and develop­
mental characteristics were normal for mice delivered of 
mothers inocula.ted with MVM. 
Teratogenic studies with Colorado tick fever (CTP) 
virus infection in mice revealed a high incidence of still­
births (6 to 45%) and neonatal deaths (26 to 50%). CTF 
was demonstrated·to cross the placenta and to replicate in 
the placenta and fetus and could be isolated from still­
borns, newborns, and dead neonates. Several developmental 
aberrations were noted in neonates; however, there was no 
weight nor growth rate abnormality noted in the survivors. 
The teratogenic effects of CTF virus were inhibited signi­
ficantly by neutralization with specific CTF antiserum, 
proving that•the teratogenic effects seen were due to CTF 
virus. 
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